{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:51:04Z","timestamp":1794556264797,"version":"4.9.1"},"reference-count":237,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100019397","name":"University Grants Commission - South Eastern Regional Office","doi-asserted-by":"publisher","award":["995\/CSIR UGC NET JUNE 2019"],"award-info":[{"award-number":["995\/CSIR UGC NET JUNE 2019"]}],"id":[{"id":"10.13039\/501100019397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["109-2320-B-255-001"],"award-info":[{"award-number":["109-2320-B-255-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chang Gung University of Science and Technology","award":["ZRRPF3P0081"],"award-info":[{"award-number":["ZRRPF3P0081"]}]},{"name":"Chang Gung University of Science and Technology","award":["ZRRPF3N0091"],"award-info":[{"award-number":["ZRRPF3N0091"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12272-025-01555-z","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T02:53:29Z","timestamp":1753412009000},"page":"577-637","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Targeting NF-\u03baB in diabetic nephropathy: exploring the therapeutic potential of phytoconstituents"],"prefix":"10.1007","volume":"48","author":[{"given":"Beena Levakumar","family":"Abhirami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anithakumari Aswathy","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2197-7713","authenticated-orcid":false,"given":"Alaganandam","family":"Kumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9800-2677","authenticated-orcid":false,"given":"Chun-Hui","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"1555_CR1","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.eujim.2024.102344","volume":"66","author":"BL Abhirami","year":"2024","unstructured":"Abhirami BL, Krishna AA, Jasim AR, Kumaran A (2024) Acacia leucophloea (Roxb.) Willd.: Multi-targeted therapeutic efficacy against type 2 diabetes mellitus. Eur J Integr Med 66:102344. https:\/\/doi.org\/10.1016\/j.eujim.2024.102344","journal-title":"Eur J Integr Med"},{"key":"1555_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.dsx.2015.02.008","volume":"9","author":"J Ahmad","year":"2015","unstructured":"Ahmad J (2015) Management of diabetic nephropathy: recent progress and future perspective. Diabetes Metab Syndrome: Clin Res Rev 9:343\u2013358. https:\/\/doi.org\/10.1016\/j.dsx.2015.02.008","journal-title":"Diabetes Metab Syndrome: Clin Res Rev"},{"key":"1555_CR3","first-page":"62","volume":"2","author":"HA Ahmed","year":"2018","unstructured":"Ahmed HA (2018) Anchomanes difformis: A multipurpose phytomedicine. IOSR J Pharm Biol Sci 2:62\u201365","journal-title":"IOSR J Pharm Biol Sci"},{"key":"1555_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7123\/01.ejim.0000425960.41858.d5","volume":"25","author":"KY Ahmed","year":"2013","unstructured":"Ahmed KY, El-Bazz WF, Mohamed HA, Elkeshky MM (2013) Transforming growth factor-\u03b2 in diabetic nephropathy. Egypt J Intern Med 25:20\u201326. https:\/\/doi.org\/10.7123\/01.ejim.0000425960.41858.d5","journal-title":"Egypt J Intern Med"},{"key":"1555_CR5","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s10753-016-0413-4","volume":"39","author":"S Ahmed","year":"2016","unstructured":"Ahmed S, Mundhe N, Borgohain M, Chowdhury L, Kwatra M, Bolshette N, Ahmed A, Lahkar M (2016) Diosmin modulates the NF-\u03baB signal transduction pathways and downregulation of various oxidative stress markers in alloxan-induced diabetic nephropathy. Inflammation 39:1783\u20131797. https:\/\/doi.org\/10.1007\/s10753-016-0413-4","journal-title":"Inflammation"},{"key":"1555_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2024.100557","author":"AM Ajayi","year":"2024","unstructured":"Ajayi AM, Akintelu TE, Igari FO, Okubena O, Umukoro S (2024) Sorghum bicolor polyphenol-rich extract improves insulin sensitivity and protects against chronic stress exacerbated diabetic nephropathy through modulation of Nrf2\/NF-\u03baB. Obes Med. https:\/\/doi.org\/10.1016\/j.obmed.2024.100557","journal-title":"Obes Med"},{"key":"1555_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ejphar.2018.10.044","volume":"842","author":"MR Akanda","year":"2019","unstructured":"Akanda MR, Uddin MN, Kim IS, Ahn D, Tae HJ, Park BY (2019) The biological and pharmacological roles of polyphenol flavonoid tilianin. Eur J Pharmacol 842:291\u2013297. https:\/\/doi.org\/10.1016\/j.ejphar.2018.10.044","journal-title":"Eur J Pharmacol"},{"key":"1555_CR8","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3390\/ijerph19031864","volume":"19","author":"S Akter","year":"2022","unstructured":"Akter S, Moni A, Faisal GM, Uddin MR, Jahan N, Hannan MA, Rahman A, Uddin MJ (2022) Renoprotective effects of mangiferin: pharmacological advances and future perspectives. Int J Environ Res Public Health 19:1864. https:\/\/doi.org\/10.3390\/ijerph19031864","journal-title":"Int J Environ Res Public Health"},{"key":"1555_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/plants10020300","volume":"10","author":"TD Alabi","year":"2021","unstructured":"Alabi TD, Brooks NL, Oguntibeju OO (2021) Leaf extracts of Anchomanes difformis ameliorated kidney and pancreatic damage in type 2 diabetes. Plants 10:1\u201326. https:\/\/doi.org\/10.3390\/plants10020300","journal-title":"Plants"},{"key":"1555_CR10","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2174\/0929867311320070007","volume":"20","author":"A Alqahtani","year":"2013","unstructured":"Alqahtani A, Hamid K, Kam A, Wong KH, Abdelhak Z, Razmovski NV, Chan K, Li KM, Groundwater PW, Li GQ (2013) The pentacyclic triterpenoids in herbal medicines and their pharmacological activities in diabetes and diabetic complications. Curr Med Chem 20:908\u2013931. https:\/\/doi.org\/10.2174\/0929867311320070007","journal-title":"Curr Med Chem"},{"key":"1555_CR11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/toxics10070362","volume":"10","author":"SM Alsuliam","year":"2022","unstructured":"Alsuliam SM, Albadr NA, Almaiman SA, Al-Khalifah AS, Alkhaldy NS, Alshammari GM (2022) Fenugreek seed galactomannan aqueous and extract protects against diabetic nephropathy and liver damage by targeting NF-\u03baB and Keap1\/Nrf2 Axis. Toxics 10:362. https:\/\/doi.org\/10.3390\/toxics10070362","journal-title":"Toxics"},{"key":"1555_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2023.103720","volume":"30","author":"SM Alsuliam","year":"2023","unstructured":"Alsuliam SM, Albadr NA, Alshammari GM, Almaiman SA, Yagoub AE, Saleh A, Yahya MA (2023) Lepidium sativum alleviates diabetic nephropathy in a rat model by attenuating glucose levels, oxidative stress and inflammation with concomitant suppression of TGF-\u03b21. Saudi J Biol Sci 30:103720. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103720","journal-title":"Saudi J Biol Sci"},{"key":"1555_CR13","doi-asserted-by":"publisher","first-page":"117573","DOI":"10.1016\/j.jep.2023.117573","volume":"322","author":"MM Apte","year":"2024","unstructured":"Apte MM, Khattar E, Tupe RS (2024) Mechanistic role of Syzygium cumini (L.) Skeels in glycation induced diabetic nephropathy via RAGE\u2013NF\u2013\u03baB pathway and extracellular proteins modifications: a molecular approach. J Ethnopharmacol 322:117573. https:\/\/doi.org\/10.1016\/j.jep.2023.117573","journal-title":"J Ethnopharmacol"},{"key":"1555_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S2221-1691(12)60050-1","volume":"2","author":"M Ayyanar","year":"2012","unstructured":"Ayyanar M, Subash-Babu P (2012) Syzygium cumini (L.) Skeels: a review of its phytochemical constituents and traditional uses. Asian Pac J Trop Biomed 2:240\u2013246. https:\/\/doi.org\/10.1016\/S2221-1691(12)60050-1","journal-title":"Asian Pac J Trop Biomed"},{"key":"1555_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13098-024-01330-y","volume":"16","author":"WM Aziz","year":"2024","unstructured":"Aziz WM, Ahmed SA, Shaker SE, Fayed DB, Metwally NS, Shawky H (2024) Portulaca oleracea L seed extracts counteract diabetic nephropathy through SDF-1\/IL10\/PPAR\u03b3\u2013mediated tuning of keap1\/Nrf2 and NF-\u03baB transcription in sprague dawley rats. Diabetol Metab Syndr 16:119. https:\/\/doi.org\/10.1186\/s13098-024-01330-y","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"1555_CR16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.34067\/kid.0001672021","volume":"360","author":"GL Bakris","year":"2021","unstructured":"Bakris GL, Mikami H, Hirata M, Nakajima A, Cressman MD (2021) A non-purine xanthine oxidoreductase inhibitor reduces albuminuria in patients with DKD: a randomized controlled trial. Kidney 360(2):1240\u20131250. https:\/\/doi.org\/10.34067\/kid.0001672021","journal-title":"Kidney"},{"key":"1555_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/biof.1815","volume":"48","author":"S Bandopadhyay","year":"2022","unstructured":"Bandopadhyay S, Anand U, Gadekar VS, Jha NK, Gupta PK, Behl T, Kumar M, Radha SMS, Dey A (2022) Dioscin: a review on pharmacological properties and therapeutic values. BioFactors 48:22\u201355","journal-title":"BioFactors"},{"key":"1555_CR18","doi-asserted-by":"publisher","first-page":"118684","DOI":"10.1016\/j.jep.2024.118684","volume":"336","author":"NS Bangar","year":"2024","unstructured":"Bangar NS, Dixit A, Apte MM, Tupe RS (2024) Syzygium cumini (L.) skeels mitigate diabetic nephropathy by regulating Nrf2 pathway and mitocyhondrial dysfunction: In vitro and in vivo studies. J Ethnopharmacol 336:118684. https:\/\/doi.org\/10.1016\/j.jep.2024.118684","journal-title":"J Ethnopharmacol"},{"key":"1555_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/dom.13969","volume":"22","author":"J Barrera-Chimal","year":"2020","unstructured":"Barrera-Chimal J, Jaisser F (2020) Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets. Diabetes Obes Metab 22:16\u201331. https:\/\/doi.org\/10.1111\/dom.13969","journal-title":"Diabetes Obes Metab"},{"key":"1555_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114743","volume":"283","author":"P Basist","year":"2022","unstructured":"Basist P, Parveen B, Zahiruddin S, Gautam G, Parveen R, Khan MA, Krishnan A, Shahid M, Ahmad S (2022) Potential nephroprotective phytochemicals: Mechanism and future prospects. J Ethnopharmacol 283:114743. https:\/\/doi.org\/10.1016\/j.jep.2021.114743","journal-title":"J Ethnopharmacol"},{"key":"1555_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/0014-5793(88)80543-x","volume":"239","author":"L Baud","year":"1988","unstructured":"Baud L, Perez J, Friedlander G, Ardaillou R (1988) Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat-cultured mesangial cells. FEBS Lett 239:50\u201354. https:\/\/doi.org\/10.1016\/0014-5793(88)80543-x","journal-title":"FEBS Lett"},{"key":"1555_CR22","doi-asserted-by":"publisher","first-page":"205435811667534","DOI":"10.1177\/2054358116675343","volume":"3","author":"S Beddhu","year":"2016","unstructured":"Beddhu S, Filipowicz R, Wang B, Wei G, Chen X, Roy AC, DuVall SL, Farrukh H, Habib AN, Bjordahl T, Simmons DL (2016) A randomized controlled trial of the effects of febuxostat therapy on adipokines and markers of kidney fibrosis in asymptomatic hyperuricemic patients with diabetic nephropathy. Can J Kidney Health Dis 3:2054358116675343. https:\/\/doi.org\/10.1177\/2054358116675343","journal-title":"Can J Kidney Health Dis"},{"key":"1555_CR23","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.3390\/molecules26113374","volume":"26","author":"S Bhambhani","year":"2021","unstructured":"Bhambhani S, Kondhare KR, Giri AP (2021) Diversity in chemical structures and biological properties of plant alkaloids. Molecules 26:3374. https:\/\/doi.org\/10.3390\/molecules26113374","journal-title":"Molecules"},{"key":"1555_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.582506","volume":"11","author":"R Bharti","year":"2021","unstructured":"Bharti R, Chopra BS, Raut S, Khatri N (2021) Pueraria tuberosa: A review on traditional uses, pharmacology and phytochemistry. Front Pharmacol 11:582506. https:\/\/doi.org\/10.3389\/fphar.2020.582506","journal-title":"Front Pharmacol"},{"key":"1555_CR25","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/bcpt.12718","volume":"120","author":"MP Borgohain","year":"2017","unstructured":"Borgohain MP, Chowdhury L, Ahmed S, Bolshette N, Devasani K, Das TJ, Mohapatra A, Lahkar M (2017) Small molecule inhibiting nuclear factor-kB ameliorates oxidative stress and suppresses renal inflammation in early stage of alloxan-induced diabetic nephropathy in rat. Basic Clin Pharmacol Toxicol 120:442\u2013449. https:\/\/doi.org\/10.1111\/bcpt.12718","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1555_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/nejmoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, De Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861\u2013869. https:\/\/doi.org\/10.1056\/nejmoa011161","journal-title":"N Engl J Med"},{"key":"1555_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.151941","volume":"225","author":"S Cai","year":"2020","unstructured":"Cai S, Chen J, Li Y (2020) Dioscin protects against diabetic nephropathy by inhibiting renal inflammation through TLR4\/NF-\u03baB pathway in mice. Immunobiology 225:151941. https:\/\/doi.org\/10.1016\/j.imbio.2020.151941","journal-title":"Immunobiology"},{"key":"1555_CR28","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/nejmoa2004967","volume":"383","author":"CP Cannon","year":"2020","unstructured":"Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, Charbonnel B, Frederich R, Gallo S, Cosentino F, Shih WJ (2020) Cardiovascular outcomes with ertugliflozin in type 2 diabetes. N Engl J Med 383:1425\u20131435. https:\/\/doi.org\/10.1056\/nejmoa2004967","journal-title":"N Engl J Med"},{"key":"1555_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1440-1797.2005.00455.x","volume":"10","author":"DR Cha","year":"2005","unstructured":"Cha DR, Kang YS, Han SY, Jee YH, Han KH, Kim HK, Han JY, Kim YS (2005) Role of aldosterone in diabetic nephropathy. Nephrol 10:37\u201339. https:\/\/doi.org\/10.1111\/j.1440-1797.2005.00455.x","journal-title":"Nephrol"},{"key":"1555_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s11676-013-0369-2","volume":"24","author":"S Chanda","year":"2013","unstructured":"Chanda S, Sarethy IP, De B, Singh K (2013) Paederia foetida - a promising ethno-medicinal tribal plant of northeastern India. J for Res (Harbin) 24:801\u2013808. https:\/\/doi.org\/10.1007\/s11676-013-0369-2","journal-title":"J for Res (Harbin)"},{"key":"1555_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jpha.2021.07.002","volume":"12","author":"A Chauhan","year":"2022","unstructured":"Chauhan A, Islam AU, Prakash H, Singh S (2022) Phytochemicals targeting NF-\u03baB signaling: Potential anti-cancer interventions. J Pharm Anal 12:394\u2013405","journal-title":"J Pharm Anal"},{"key":"1555_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3892\/ijmm.2012.955","volume":"30","author":"P Chen","year":"2012","unstructured":"Chen P, Shi Q, Xu X, Wang Y, Chen W, Wang H (2012) Quercetin suppresses NF-\u03baB and MCP-1 expression in a high glucose-induced human mesangial cell proliferation model. Int J Mol Med 30:119\u2013125. https:\/\/doi.org\/10.3892\/ijmm.2012.955","journal-title":"Int J Mol Med"},{"key":"1555_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jff.2016.01.023","volume":"22","author":"L Chen","year":"2016","unstructured":"Chen L, Tian G, Tang W, Luo W, Liu P, Ma Z (2016) Protective effect of luteolin on streptozotocin-induced diabetic renal damage in mice via the regulation of RIP140\/NF-\u039aB pathway and insulin signalling pathway. J Funct Foods 22:93\u2013100. https:\/\/doi.org\/10.1016\/j.jff.2016.01.023","journal-title":"J Funct Foods"},{"key":"1555_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.958790","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Liu Q, He J, Li Y (2022) Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target. Front Immunol 13:958790. https:\/\/doi.org\/10.3389\/fimmu.2022.958790","journal-title":"Front Immunol"},{"key":"1555_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2024.116534","volume":"253","author":"R Chen","year":"2025","unstructured":"Chen R, Fan J, Wu Y, Huang X, Zhang W, Xu Y, Zhang Y, Li L, Wang C, Yu M, Zhu Y (2025) Strobilanthes sarcorrhiza root phenolic extract prevent diabetic nephropathy in mice by regulating NF-\u03baB\/IL-1\u03b2 signaling and glycerophospholipid metabolism. J Pharm Biomed Anal 253:116534. https:\/\/doi.org\/10.1016\/j.jpba.2024.116534","journal-title":"J Pharm Biomed Anal"},{"key":"1555_CR36","doi-asserted-by":"publisher","first-page":"152643","DOI":"10.1016\/j.prp.2019.152643","volume":"215","author":"AS Chhipa","year":"2019","unstructured":"Chhipa AS, Borse SP, Baksi R, Lalotra S, Nivsarkar M (2019) Targeting receptors of advanced glycation end products (RAGE): preventing diabetes-induced cancer and diabetic complications. Pathol Res Pract 215:152643. https:\/\/doi.org\/10.1016\/j.prp.2019.152643","journal-title":"Pathol Res Pract"},{"key":"1555_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fphar.2019.00027","volume":"10","author":"S Chowdhury","year":"2019","unstructured":"Chowdhury S, Ghosh S, Das AK, Sil PC (2019) Sil, ferulic acid protects hyperglycemia-induced kidney damage by regulating oxidative insult, inflammation and autophagy. Front Pharmacol 10:27. https:\/\/doi.org\/10.3389\/fphar.2019.00027","journal-title":"Front Pharmacol"},{"key":"1555_CR38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrneph.2010.54","volume":"6","author":"V D\u2019Agati","year":"2010","unstructured":"D\u2019Agati V, Schmidt AM (2010) RAGE and the pathogenesis of chronic kidney disease. Nat Rev Nephrol 6:352\u2013360. https:\/\/doi.org\/10.1038\/nrneph.2010.54","journal-title":"Nat Rev Nephrol"},{"key":"1555_CR39","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00011-017-1087-6","volume":"66","author":"T Dai","year":"2017","unstructured":"Dai T, Shi K, Chen G, Shen Y, Pan T (2017) Malvidin attenuates pain and inflammation in rats with osteoarthritis by suppressing the NF-\u03baB signaling pathway. Inflamm Res 66:1075\u20131084. https:\/\/doi.org\/10.1007\/s00011-017-1087-6","journal-title":"Inflamm Res"},{"key":"1555_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s2213-8587(15)00261-2","volume":"3","author":"D De Zeeuw","year":"2015","unstructured":"De Zeeuw D, Bekker P, Henkel E, Hasslacher C, Gouni-Berthold I, Mehling H, Potarca A, Tesar V, Heerspink HJ, Schall TJ (2015) The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial. Lancet Diabetes Endocrinol 3:687\u2013696. https:\/\/doi.org\/10.1016\/s2213-8587(15)00261-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1555_CR41","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/14787210.2021.1863145","volume":"19","author":"M Deng","year":"2021","unstructured":"Deng M, Chen H, Long J, Song J, Xie L, Li X (2021) Calycosin: a review of its pharmacological effects and application prospects. Expert Rev Anti-Infect Ther 19:911\u2013925. https:\/\/doi.org\/10.1080\/14787210.2021.1863145","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"1555_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/mc.20170","volume":"45","author":"CS Divya","year":"2006","unstructured":"Divya CS, Pillai MR (2006) Antitumor action of curcumin in human papillomavirus-associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation and modulation of apoptosis. Mol Carcinog 45:320\u2013332. https:\/\/doi.org\/10.1002\/mc.20170","journal-title":"Mol Carcinog"},{"key":"1555_CR43","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/jcm9020458","volume":"9","author":"J Donate-Correa","year":"2020","unstructured":"Donate-Correa J, Luis-Rodr\u00edguez D, Mart\u00edn-N\u00fa\u00f1ez E, Tagua VG, Hern\u00e1ndez-Carballo C, Ferri C, Rodr\u00edguez-Rodr\u00edguez AE, Mora-Fern\u00e1ndez C, Navarro-Gonz\u00e1lez JF (2020) Inflammatory targets in diabetic nephropathy. J Clin Med 9:458. https:\/\/doi.org\/10.3390\/jcm9020458","journal-title":"J Clin Med"},{"key":"1555_CR44","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1002\/jcp.29452","volume":"235","author":"N Dong","year":"2020","unstructured":"Dong N, Li X, Xue C, Zhang L, Wang C, Xu X, Shan A (2020a) Astragalus polysaccharides alleviates LPS-induced inflammation via the NF-\u03baB\/MAPK signaling pathway. J Cell Physiol 235:5525\u20135540. https:\/\/doi.org\/10.1002\/jcp.29452","journal-title":"J Cell Physiol"},{"key":"1555_CR45","doi-asserted-by":"publisher","first-page":"13405","DOI":"10.1111\/jfbc.13405","volume":"44","author":"WH Dong","year":"2020","unstructured":"Dong WH, Chu QQ, Liu SQ, Deng DT, Xu Q (2020b) Isobavachalcone ameliorates diabetic nephropathy in rats by inhibiting the NF-\u03baB pathway. J Food Biochem 44:13405. https:\/\/doi.org\/10.1111\/jfbc.13405","journal-title":"J Food Biochem"},{"key":"1555_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pathophys.2015.02.001","volume":"22","author":"OO Elekofehinti","year":"2015","unstructured":"Elekofehinti OO (2015) Saponins: Anti-diabetic principles from medicinal plants\u2013A review. Pathophysiology 22:95\u2013103. https:\/\/doi.org\/10.1016\/j.pathophys.2015.02.001","journal-title":"Pathophysiology"},{"key":"1555_CR47","doi-asserted-by":"publisher","first-page":"12917","DOI":"10.3390\/ijms241612917","volume":"24","author":"M Feldo","year":"2023","unstructured":"Feldo M, W\u00f3jciak M, Dresler S, Sowa P, P\u0142achno BJ, Samborski D, Sowa I (2023) Effect of Diosmin on selected parameters of oxygen homeostasis. Int J Mol Sci 24:12917. https:\/\/doi.org\/10.3390\/ijms241612917","journal-title":"Int J Mol Sci"},{"key":"1555_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156314","author":"Q Feng","year":"2025","unstructured":"Feng Q, Yu X, Xie J, Liu F, Zhang X, Li S, Wang Y, Pan S, Liu D, Liu Z (2025) Phillygenin improves diabetic nephropathy by inhibiting inflammation and apoptosis via regulating TLR4\/MyD88\/NF-\u03baB and PI3K\/AKT\/GSK3\u03b2 signaling pathways. Phytomedicine. https:\/\/doi.org\/10.1016\/j.phymed.2024.156314","journal-title":"Phytomedicine"},{"key":"1555_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/circulationaha.121.057983","volume":"145","author":"G Filippatos","year":"2022","unstructured":"Filippatos G, Anker SD, Agarwal R, Ruilope LM, Rossing P, Bakris GL, Tasto C, Joseph A, Kolkhof P, Lage A, Pitt B (2022) Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD trial. Circulation 145:437\u2013447. https:\/\/doi.org\/10.1161\/circulationaha.121.057983","journal-title":"Circulation"},{"key":"1555_CR50","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/014107680109400504","volume":"94","author":"L Foggensteiner","year":"2001","unstructured":"Foggensteiner L, Mulroy S, Firth J (2001) Management of diabetic nephropathy. J R Soc Med 94:210\u2013217. https:\/\/doi.org\/10.1177\/014107680109400504","journal-title":"J R Soc Med"},{"key":"1555_CR51","doi-asserted-by":"publisher","first-page":"8507453","DOI":"10.1155\/2019\/8507453","volume":"1","author":"GA Geberemeskel","year":"2019","unstructured":"Geberemeskel GA, Debebe YG, Nguse NA (2019) Antidiabetic effect of fenugreek seed powder solution (Trigonella foenum-graecum L.) on hyperlipidemia in diabetic patients. J Diabetes Res 1:8507453. https:\/\/doi.org\/10.1155\/2019\/8507453","journal-title":"J Diabetes Res"},{"key":"1555_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0140-6736(19)31149-3","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Ryd\u00e9n L, Xavier D (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet 394:121\u2013130. https:\/\/doi.org\/10.1016\/s0140-6736(19)31149-3","journal-title":"Lancet"},{"key":"1555_CR53","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/nejmoa2108269","volume":"385","author":"HC Gerstein","year":"2021","unstructured":"Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CS, Khurmi NS, Heenan L, Del Prato S, Dyal L (2021) Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes. N Engl J Med 385:896\u2013907. https:\/\/doi.org\/10.1056\/nejmoa2108269","journal-title":"N Engl J Med"},{"key":"1555_CR54","first-page":"49","volume":"5","author":"O Gheith","year":"2016","unstructured":"Gheith O (2016) Diabetic kidney disease: worldwide difference of prevalence and risk factors. J Nephropharmacol 5:49\u201356","journal-title":"J Nephropharmacol"},{"key":"1555_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2022.100379","volume":"2","author":"S Ghosh","year":"2022","unstructured":"Ghosh S, Ghosh A, Rajanan A, Suresh AJ, Raut PS, Kundu S, Sahu BD (2022) Natural coumarins: preclinical evidence-based potential candidates to alleviate diabetic nephropathy. Phytomed plus 2:100379. https:\/\/doi.org\/10.1016\/j.phyplu.2022.100379","journal-title":"Phytomed plus"},{"key":"1555_CR56","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/biomedicines11020291","volume":"11","author":"RV Giglio","year":"2023","unstructured":"Giglio RV, Patti AM, Rizvi AA (2023) Advances in the pharmacological management of diabetic nephropathy: a 2022 international update. Biomedicines 11:291. https:\/\/doi.org\/10.3390\/biomedicines11020291","journal-title":"Biomedicines"},{"key":"1555_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11101-013-9293-5","volume":"13","author":"A Golan-Goldhirsh","year":"2014","unstructured":"Golan-Goldhirsh A, Gopas J (2014) Plant-Derived Inhibitors of NF-\u039ab. Phytochem Rev 13:107\u2013121. https:\/\/doi.org\/10.1007\/s11101-013-9293-5","journal-title":"Phytochem Rev"},{"key":"1555_CR58","doi-asserted-by":"publisher","first-page":"9054","DOI":"10.1039\/d1fo01182k","volume":"12","author":"P Gong","year":"2021","unstructured":"Gong P, Cui D, Guo Y, Wang M, Wang Z, Huang Z, Yang W, Chen F, Chen X (2021) A novel polysaccharide obtained from: Siraitia grosvenorii alleviates inflammatory responses in a diabetic nephropathy mouse model via the TLR4-NF-\u03baB pathway. Food Funct 12:9054\u20139065. https:\/\/doi.org\/10.1039\/d1fo01182k","journal-title":"Food Funct"},{"key":"1555_CR59","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.2147\/DDDT.S266911","volume":"14","author":"R Guo","year":"2020","unstructured":"Guo R, Li L, Su J, Li S, Duncan SE, Liu Z, Fan G (2020) Pharmacological activity and mechanism of tanshinone II A in related diseases. Drug des Devel Ther 14:4735\u20134748","journal-title":"Drug des Devel Ther"},{"key":"1555_CR60","doi-asserted-by":"publisher","first-page":"115025","DOI":"10.1016\/j.biopha.2023.115025","volume":"165","author":"W Guo","year":"2023","unstructured":"Guo W, Li H, Li Y, Kong W (2023) Renal intrinsic cells remodeling in diabetic kidney disease and the regulatory effects of SGLT2 Inhibitors. Biomed Pharmacother 165:115025. https:\/\/doi.org\/10.1016\/j.biopha.2023.115025","journal-title":"Biomed Pharmacother"},{"key":"1555_CR61","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2147\/DDDT.S411211","volume":"17","author":"M Guo","year":"2023","unstructured":"Guo M, Gao J, Jiang L, Dai Y (2023) Astragalus polysaccharide ameliorates renal inflammatory responses in a diabetic nephropathy by suppressing the TLR4\/NF-\u03baB Pathway. Drug des Devel Ther 17:2107\u20132118. https:\/\/doi.org\/10.2147\/DDDT.S411211","journal-title":"Drug des Devel Ther"},{"key":"1555_CR62","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","volume":"1799","author":"SC Gupta","year":"2010","unstructured":"Gupta SC, Sundaram C, Reuter S, Aggarwal BB (2010) Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta Gene Regul Mech 1799:775\u2013787. https:\/\/doi.org\/10.1016\/j.bbagrm.2010.05.004","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"1555_CR63","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.2174\/138161209788489177","volume":"15","author":"H Hanai","year":"2009","unstructured":"Hanai H, Sugimoto K (2009) Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr Pharm des 15:2087\u20132094. https:\/\/doi.org\/10.2174\/138161209788489177","journal-title":"Curr Pharm des"},{"key":"1555_CR64","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/s1875-5364(19)30040-8","volume":"17","author":"WA Han-Qing","year":"2019","unstructured":"Han-Qing WA, Sha-Sha WA, Chiufai K, Qi WA, Cheng XL (2019) Chinese Journal of Natural Medicines Umbelliferone ameliorates renal function in diabetic nephropathy rats through regulating inflammation and TLR\/NF-\u03baB pathway. Chin J Nat Med 17:346\u2013354. https:\/\/doi.org\/10.1016\/s1875-5364(19)30040-8","journal-title":"Chin J Nat Med"},{"key":"1555_CR65","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/ptr.6855","volume":"35","author":"IU Haq","year":"2021","unstructured":"Haq IU, Imran M, Nadeem M, Tufail T, Gondal TA, Mubarak MS (2021) Piperine: a review of its biological effects. Phytother Res 35:680\u2013700. https:\/\/doi.org\/10.1002\/ptr.6855","journal-title":"Phytother Res"},{"key":"1555_CR66","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5114\/pja.2023.131708","volume":"10","author":"G Harvanov\u00e1","year":"2023","unstructured":"Harvanov\u00e1 G, Durankov\u00e1 S, Bernasovsk\u00e1 J (2023) The role of cytokines and chemokines in the inflammatory response. Alergologia Polska\u2014Polish J Allergol 10:210\u2013219. https:\/\/doi.org\/10.5114\/pja.2023.131708","journal-title":"Alergologia Polska\u2014Polish J Allergol"},{"key":"1555_CR67","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1507\/endocrj.k10e-382","volume":"58","author":"S Hattori","year":"2011","unstructured":"Hattori S (2011) Sitagliptin reduces albuminuria in patients with type 2 diabetes. Endocr J 58:69\u201373. https:\/\/doi.org\/10.1507\/endocrj.k10e-382","journal-title":"Endocr J"},{"key":"1555_CR68","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cr.2011.13","volume":"21","author":"MS Hayden","year":"2011","unstructured":"Hayden MS, Ghosh S (2011) NF-\u03baB in immunobiology. Cell Res 21:223\u2013244. https:\/\/doi.org\/10.1038\/cr.2011.13","journal-title":"Cell Res"},{"key":"1555_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2011.01.103","author":"FQ He","year":"2011","unstructured":"He FQ, Qiu BY, Zhang XH, Li TK, Xie Q, Cui DJ, Huang XL, Gan HT (2011) Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-\u03baB activation in a rat model of Alzheimer\u2019s disease induced by amyloid-\u03b2 (1\u201342). Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2011.01.103","journal-title":"Brain Res"},{"key":"1555_CR70","doi-asserted-by":"publisher","first-page":"155932582211057","DOI":"10.1177\/15593258221105704","volume":"20","author":"C He","year":"2022","unstructured":"He C, Wang D, Wang R, Huang Y, Huang X, Shen S, Lv J, Wu M (2022) Epigallocatechin gallate induces the demethylation of actinin alpha 4 to inhibit diabetic nephropathy renal fibrosis via the NF-\u03baB signaling pathway in Vitro. Dose-Response 20:15593258221105704. https:\/\/doi.org\/10.1177\/15593258221105704","journal-title":"Dose-Response"},{"key":"1555_CR71","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/pharmaceutics15092235","volume":"15","author":"G He","year":"2023","unstructured":"He G, Chen G, Liu W, Ye D, Liu X, Liang X, Song J (2023) Salvianolic Acid B: a review of pharmacological effects, safety, combination therapy, new dosage forms and novel drug delivery routes. Pharmaceutics 15:2235. https:\/\/doi.org\/10.3390\/pharmaceutics15092235","journal-title":"Pharmaceutics"},{"key":"1555_CR72","doi-asserted-by":"publisher","first-page":"714","DOI":"10.4274\/tjps.galenos.2021.07504","volume":"19","author":"Y Hekmatshoar","year":"2022","unstructured":"Hekmatshoar Y, \u00d6zkan T, Rahbar Saadat Y (2022) Evidence for health-promoting properties of Lepidium sativum L.: an updated comprehensive review. Turk J Pharm Sci 19:714\u2013723. https:\/\/doi.org\/10.4274\/tjps.galenos.2021.07504","journal-title":"Turk J Pharm Sci"},{"key":"1555_CR73","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000256659","volume":"31","author":"CE Hills","year":"2010","unstructured":"Hills CE, Squires PE (2010) TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol 31:68\u201374. https:\/\/doi.org\/10.1159\/000256659","journal-title":"Am J Nephrol"},{"key":"1555_CR74","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00125-011-2409-9","volume":"55","author":"CE Hills","year":"2012","unstructured":"Hills CE, Siamantouras E, Smith SW, Cockwell P, Liu KK, Squires PE (2012) TGF\u03b2 modulates cell-to-cell communication in early epithelial-to-mesenchymal transition. Diabetologia 55:812\u2013824. https:\/\/doi.org\/10.1007\/s00125-011-2409-9","journal-title":"Diabetologia"},{"key":"1555_CR75","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1126\/science.1071914","volume":"298","author":"A Hoffmann","year":"2002","unstructured":"Hoffmann A, Levchenko A, Scott ML, Baltimore D (2002) The I\u03baB-NF-\u03baB signaling module: temporal control and selective gene activation. Science 298:1241\u20131245. https:\/\/doi.org\/10.1126\/science.1071914","journal-title":"Science"},{"key":"1555_CR76","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000447434","volume":"133","author":"R Hojs","year":"2016","unstructured":"Hojs R, Ekart R, Bevc S, Hojs N (2016) Markers of inflammation and oxidative stress in the development and progression of renal disease in diabetic patients. Nephron 133:159\u2013162. https:\/\/doi.org\/10.1159\/000447434","journal-title":"Nephron"},{"key":"1555_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114252","volume":"159","author":"Q Hu","year":"2023","unstructured":"Hu Q, Chen Y, Deng X, Li Y, Ma X, Zeng J, Zhao Y (2023) Diabetic nephropathy: focusing on pathological signals, clinical treatment and dietary regulation. Biomed Pharmacother 159:114252. https:\/\/doi.org\/10.1016\/j.biopha.2023.114252","journal-title":"Biomed Pharmacother"},{"key":"1555_CR78","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3390\/ijms24032136","volume":"24","author":"L Huang","year":"2023","unstructured":"Huang L, Kim MY, Cho JY (2023a) Immunopharmacological activities of luteolin in chronic diseases. Int J Mol Sci 24:2136. https:\/\/doi.org\/10.3390\/ijms24032136","journal-title":"Int J Mol Sci"},{"key":"1555_CR79","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1875-5364(23)60427-3","volume":"21","author":"Q Huang","year":"2023","unstructured":"Huang Q, Zhang Y, Jiang Y, Huang L, Liu Q, Ouyang D (2023b) Eucommia lignans alleviate the progression of diabetic nephropathy through mediating the AR\/Nrf2\/HO-1\/AMPK axis in vivo and in vitro. Chin J Nat Med 21:516\u2013526. https:\/\/doi.org\/10.1016\/S1875-5364(23)60427-3","journal-title":"Chin J Nat Med"},{"key":"1555_CR236","doi-asserted-by":"publisher","unstructured":"Ibrahim SR, Altyar AE, Sindi IA, El-Agamy DS, Abdallah HM, Mohamed SG, Mohamed GA (2021) Kirenol: A promising bioactive metabolite from siegesbeckia species: A detailed review. J. Ethnopharmacol. Dec 5:281:114552. https:\/\/doi.org\/10.1016\/j.jep.2021.114552","DOI":"10.1016\/j.jep.2021.114552"},{"key":"1555_CR80","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.biopha.2017.03.102","volume":"90","author":"H Iskender","year":"2017","unstructured":"Iskender H, Dokumacioglu E, Sen TM, Ince I, Kanbay Y, Saral S (2017) The effect of hesperidin and quercetin on oxidative stress, NF-\u03baB and SIRT1 levels in an STZ-induced experimental diabetes model. Biomed Pharmacother 90:500\u2013508. https:\/\/doi.org\/10.1016\/j.biopha.2017.03.102","journal-title":"Biomed Pharmacother"},{"key":"1555_CR81","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jep.2012.08.048","volume":"144","author":"MN Islam","year":"2012","unstructured":"Islam MN, Choi RJ, Jin SE, Kim YS, Ahn BR, Zhao D, Jung HA, Choi JS (2012) Mechanism of anti-inflammatory activity of umbelliferone 6- carboxylic acid isolated from Angelica decursiva. J Ethnopharmacol 144:175\u2013181. https:\/\/doi.org\/10.1016\/j.jep.2012.08.048","journal-title":"J Ethnopharmacol"},{"key":"1555_CR82","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/biomedicines12051098","volume":"12","author":"R Jha","year":"2024","unstructured":"Jha R, Lopez-Trevino S, Kankanamalage HR, Jha JC (2024) Diabetes and Renal Complications: an overview on pathophysiology. Biomarkers Therapeutic Interventions Biomed 12:1098. https:\/\/doi.org\/10.3390\/biomedicines12051098","journal-title":"Biomarkers Therapeutic Interventions Biomed"},{"key":"1555_CR83","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mce.2010.07.023","volume":"331","author":"Q Jiang","year":"2011","unstructured":"Jiang Q, Liu P, Wu X, Liu W, Shen X, Lan T, Xu S, Peng J, Xie X, Huang H (2011) Berberine attenuates lipopolysaccharide-induced extracellular matrix accumulation and inflammation in rat mesangial cells: Involvement of NF-\u03baB signaling pathway. Mol Cell Endocrinol 331:34\u201340. https:\/\/doi.org\/10.1016\/j.mce.2010.07.023","journal-title":"Mol Cell Endocrinol"},{"key":"1555_CR84","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.12659\/MSM.910764","volume":"24","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Liu J, Zhou Z, Liu K, Liu C (2018) Diosmetin attenuates AKT signaling pathway by modulating the\u00a0nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB)\/inducible nitric oxide synthase (iNOS) in streptozotocin (STZ)-induced diabetic nephropathy mice. Med Sci Monit 24:7007\u20137014. https:\/\/doi.org\/10.12659\/MSM.910764","journal-title":"Med Sci Monit"},{"key":"1555_CR85","doi-asserted-by":"publisher","first-page":"1185317","DOI":"10.3389\/fimmu.2023.1185317","volume":"14","author":"Q Jin","year":"2023","unstructured":"Jin Q, Liu T, Qiao Y, Liu D, Yang L, Mao H, Ma F, Wang Y, Peng L, Zhan Y (2023) Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols. Front Immunol 14:1185317. https:\/\/doi.org\/10.3389\/fimmu.2023.1185317","journal-title":"Front Immunol"},{"key":"1555_CR86","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.dsx.2017.12.028","volume":"12","author":"Z Karimi","year":"2018","unstructured":"Karimi Z, Kahe F, Jamil A, Marszalek J, Ghanbari A, Afarideh M, Khajeh E, Noshad S, Esteghamati A, Chi G (2018) Intercellular adhesion molecule-1 in diabetic patients with and without microalbuminuria. Diabetes Metab Syndr 12:365\u2013368. https:\/\/doi.org\/10.1016\/j.dsx.2017.12.028","journal-title":"Diabetes Metab Syndr"},{"key":"1555_CR87","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.lwt.2011.11.003","volume":"46","author":"APP Kayod\u00e9","year":"2012","unstructured":"Kayod\u00e9 APP, Bara CA, Dalod\u00e9-Vieira G (2012) Extraction of antioxidant pigments from dye sorghum leaf sheaths. LWT 46:49\u201355. https:\/\/doi.org\/10.1016\/j.lwt.2011.11.003","journal-title":"LWT"},{"key":"1555_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-014-0364-1","volume":"13","author":"R Khanra","year":"2015","unstructured":"Khanra R, Dewanjee S, Dua T, Sahu R, Gangopadhyay M, De Feo V, Zia-Ul-Haq M (2015) Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes-induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response. J Transl Med 13:1\u20134. https:\/\/doi.org\/10.1186\/s12967-014-0364-1","journal-title":"J Transl Med"},{"key":"1555_CR89","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.biopha.2017.07.112","volume":"94","author":"R Khanra","year":"2017","unstructured":"Khanra R, Bhattacharjee N, Dua TK, Nandy A, Saha A, Kalita J, Manna P, Dewanjee S (2017) Taraxerol, a pentacyclic triterpenoid, from Abroma augusta leaf attenuates diabetic nephropathy in type 2 diabetic rats. Biomed Pharmacother 94:726\u2013741. https:\/\/doi.org\/10.1016\/j.biopha.2017.07.112","journal-title":"Biomed Pharmacother"},{"key":"1555_CR90","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4162\/nrp.2011.5.2.107","volume":"5","author":"JH Kim","year":"2011","unstructured":"Kim JH, Kang MJ, Choi HN, Jeong SM, Lee YM, Kim JI (2011) Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr Res Pract 5:107\u2013111. https:\/\/doi.org\/10.4162\/nrp.2011.5.2.107","journal-title":"Nutr Res Pract"},{"key":"1555_CR91","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/ptr.3672","volume":"26","author":"J Kim","year":"2012","unstructured":"Kim J, Lee YS, Kim CS, Kim JS (2012) Betulinic acid has an inhibitory effect on pancreatic lipase and induces adipocyte lipolysis, phytother. Res 26:1103\u20131106. https:\/\/doi.org\/10.1002\/ptr.3672","journal-title":"Res"},{"key":"1555_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110975","volume":"133","author":"M Kong","year":"2021","unstructured":"Kong M, Xie K, Lv M, Li J, Yao J, Yan K, Wu X, Xu Y, Ye D (2021) Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise. Biomed Pharmacother 133:110975. https:\/\/doi.org\/10.1016\/j.biopha.2020.110975","journal-title":"Biomed Pharmacother"},{"key":"1555_CR93","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jss.2010.01.007","volume":"171","author":"K Kudo","year":"2011","unstructured":"Kudo K, Hagiwara S, Hasegawa A, Kusaka J, Koga H, Noguchi T (2011) Cepharanthine exerts anti-inflammatory effects via NF-\u03baB inhibition in an LPS-induced rat model of systemic inflammation. J Surg Res 171:199\u2013204. https:\/\/doi.org\/10.1016\/j.jss.2010.01.007","journal-title":"J Surg Res"},{"key":"1555_CR94","doi-asserted-by":"publisher","first-page":"17810","DOI":"10.1074\/jbc.272.28.17810","volume":"272","author":"HM Lander","year":"1997","unstructured":"Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM (1997) Activation of the receptor for advanced glycation end products triggers a p21 RAS-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272:17810\u201317814. https:\/\/doi.org\/10.1074\/jbc.272.28.17810","journal-title":"J Biol Chem"},{"key":"1555_CR95","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1:1651. https:\/\/doi.org\/10.1101\/cshperspect.a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1555_CR96","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2147\/DDDT.S310882","volume":"15","author":"L Lei","year":"2021","unstructured":"Lei L, Zhao J, Liu XQ, Chen J, Qi XM, Xia LL, Wu YG (2021) Wogonin alleviates kidney tubular epithelial injury in diabetic nephropathy by inhibiting PI3K\/ AKT\/NF-\u039aB signaling pathways. Drug des Devel Ther 15:3131\u20133150. https:\/\/doi.org\/10.2147\/DDDT.S310882","journal-title":"Drug des Devel Ther"},{"key":"1555_CR97","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/nejm199311113292004","volume":"329","author":"EJ Lewis","year":"1993","unstructured":"Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456\u20131462. https:\/\/doi.org\/10.1056\/nejm199311113292004","journal-title":"N Engl J Med"},{"key":"1555_CR98","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851\u2013860","journal-title":"N Engl J Med"},{"key":"1555_CR99","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ptr.3045","volume":"24","author":"X Li","year":"2010","unstructured":"Li X, Cui X, Sun X, Li X, Zhu Q, Li W (2010) Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats. Phytother Res 24:893\u2013899. https:\/\/doi.org\/10.1002\/ptr.3045","journal-title":"Phytother Res"},{"key":"1555_CR100","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1080\/13880209.2022.2112239","volume":"60","author":"J Li","year":"2022","unstructured":"Li J, Zhang J, Yang M, Huang X, Zhang M, Fang X, Wu S (2022a) Kirenol alleviates diabetic nephropathy via regulating TGF-\u03b2\/Smads and the NF-\u03baB signal pathway. Pharm Biol 60:1690\u20131700. https:\/\/doi.org\/10.1080\/13880209.2022.2112239","journal-title":"Pharm Biol"},{"key":"1555_CR101","first-page":"78","volume":"18","author":"M Li","year":"2022","unstructured":"Li M, Feng W, Zhang W, Pang Z, Pei S, Xia L, Li Q, Li H (2022b) Efficacy of bisacurone in bone fracture healing process: An experimental study on osteoporotic rats. Pharmacogn Mag 18:78","journal-title":"Pharmacogn Mag"},{"key":"1555_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.857956","volume":"13","author":"M Li","year":"2022","unstructured":"Li M, Xie F, Wang L, Zhu G, Qi LW, Jiang S (2022c) Celastrol: an update on its hepatoprotective properties and the linked molecular mechanisms. Front Pharmacol 13:857956. https:\/\/doi.org\/10.3389\/fphar.2022.857956","journal-title":"Front Pharmacol"},{"key":"1555_CR103","doi-asserted-by":"publisher","DOI":"10.1590\/acb370601","author":"Y Li","year":"2022","unstructured":"Li Y, Ou S, Liu Q, Gan L, Zhang L, Wang Y, Qin J, Liu J, Wu W (2022d) Genistein improves mitochondrial function and inflammatory in rats with diabetic nephropathy via inhibiting MAPK\/NF-\u03baB pathway. Acta Cir Bras. https:\/\/doi.org\/10.1590\/acb370601","journal-title":"Acta Cir Bras"},{"key":"1555_CR104","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/IJNRD.S40172","volume":"7","author":"AK Lim","year":"2014","unstructured":"Lim AK (2014) Diabetic nephropathy \u2013 Complications and treatment. Int J Nephrol Renovasc Dis 7:361\u2013381. https:\/\/doi.org\/10.2147\/IJNRD.S40172","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"1555_CR105","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.clinthera.2017.07.011","volume":"40","author":"CW Lin","year":"2018","unstructured":"Lin CW, Mostafa NM, Andress DL, Brennan JJ, Klein CE, Awni WM (2018) Relationship between atrasentan concentrations and urinary albumin to creatinine ratio in Western and Japanese patients with diabetic nephropathy. Clin Ther 40:242\u2013251. https:\/\/doi.org\/10.1016\/j.clinthera.2017.07.011","journal-title":"Clin Ther"},{"key":"1555_CR106","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"key":"1555_CR107","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jtcme.2023.05.003","volume":"13","author":"YH Liu","year":"2023","unstructured":"Liu YH, Lin YS, Sie YY, Wang CC, Chang CI, Hou WC (2023) Vitisin B, a resveratrol tetramer from Vitis thunbergii var. taiwaniana, ameliorates impaired glucose regulations in nicotinamide\/streptozotocin-induced type 2 diabetic mice. J Tradit Complement Med 13:479\u2013488. https:\/\/doi.org\/10.1016\/j.jtcme.2023.05.003","journal-title":"J Tradit Complement Med"},{"key":"1555_CR108","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1681\/ASN.2011080822","volume":"23","author":"V Lopez-Parra","year":"2012","unstructured":"Lopez-Parra V, Mallavia B, Lopez-Franco O, Ortiz-Mu\u00f1oz G, Oguiza A, Recio C, Blanco J, Nimmerjahn F, Egido J, Gomez-Guerrero C (2012) Fc\u03b3 receptor deficiency attenuates diabetic nephropathy. J Am Soc Nephrol 23:1518\u20131527. https:\/\/doi.org\/10.1681\/ASN.2011080822","journal-title":"J Am Soc Nephrol"},{"key":"1555_CR109","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1472-6882-14-156","volume":"14","author":"HJ Lu","year":"2014","unstructured":"Lu HJ, Tzeng TF, Liou SS, Lin SD, Wu MC, Liu IM (2014) Polysaccharides from Liriopes Radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-\u03baB and p38 MAPK signaling pathways. BMC Complement Altern Med 14:156. https:\/\/doi.org\/10.1186\/1472-6882-14-156","journal-title":"BMC Complement Altern Med"},{"key":"1555_CR110","doi-asserted-by":"publisher","first-page":"BSR20180071","DOI":"10.1042\/BSR20180071","volume":"38","author":"J Lu","year":"2018","unstructured":"Lu J, Peng J, Xiang M, He L, Wang D, Xiong G, Li S (2018) Trichosanthes kirilowii lectin alleviates diabetic nephropathy by inhibiting the LOX1\/NF-\u03baB\/caspase-9 signaling pathway. Biosci Rep 38:BSR20180071. https:\/\/doi.org\/10.1042\/BSR20180071","journal-title":"Biosci Rep"},{"key":"1555_CR111","first-page":"195","volume":"7","author":"F Lu","year":"2019","unstructured":"Lu F, Yan X, Xu X, Akunne T, Li D (2019) Phytochemicals from Siraitia grosvenorii: new minor compounds and advances in pharmacological activities. EC Pharmacol Toxicol 7:195\u2013204","journal-title":"EC Pharmacol Toxicol"},{"key":"1555_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106467","volume":"84","author":"C Lu","year":"2020","unstructured":"Lu C, Fan G, Wang D (2020) Akebia saponin D ameliorated kidney injury and exerted anti-inflammatory and anti-apoptotic effects in diabetic nephropathy by activation of NRF2\/HO-1 and inhibition of NF-\u03baB pathway. Int Immunopharmacol 84:106467. https:\/\/doi.org\/10.1016\/j.intimp.2020.106467","journal-title":"Int Immunopharmacol"},{"key":"1555_CR113","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.sjbs.2021.11.016","volume":"29","author":"PT Lum","year":"2022","unstructured":"Lum PT, Sekar M, Gan SH, Jeyabalan S, Bonam SR, Rani NN, Ku-Mahdzir KM, Seow LJ, Wu YS, Subramaniyan V, Fuloria NK (2022) Therapeutic potential of mangiferin against kidney disorders and its mechanism of action: a review. Saudi J Biol Sci 29:1530\u20131542. https:\/\/doi.org\/10.1016\/j.sjbs.2021.11.016","journal-title":"Saudi J Biol Sci"},{"key":"1555_CR114","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.drudis.2014.10.007","volume":"20","author":"M Lv","year":"2015","unstructured":"Lv M, Chen Z, Hu G, Li Q (2015) Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives. Drug Discov Today 20:332\u2013346. https:\/\/doi.org\/10.1016\/j.drudis.2014.10.007","journal-title":"Drug Discov Today"},{"key":"1555_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2019.103702","volume":"64","author":"B Ma","year":"2020","unstructured":"Ma B, Zhu Z, Zhang J, Ren C, Zhang Q (2020) Aucubin alleviates diabetic nephropathy by inhibiting NF-\u03baB activation and inducing SIRT1\/SIRT3-FOXO3a signalling pathway in high-fat diet\/streptozotocin-induced diabetic mice. J Funct Foods 64:103702. https:\/\/doi.org\/10.1016\/j.jff.2019.103702","journal-title":"J Funct Foods"},{"key":"1555_CR116","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1177\/147323000503300610","volume":"33","author":"H Makino","year":"2005","unstructured":"Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S (2005) The telmisartan renoprotective study from incipient nephropathy to overt nephropathy\u2013rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study. J Int Med Res 33:677\u2013686. https:\/\/doi.org\/10.1177\/147323000503300610","journal-title":"J Int Med Res"},{"key":"1555_CR117","doi-asserted-by":"publisher","first-page":"F414","DOI":"10.1152\/ajprenal.00393.2016","volume":"313","author":"S Malik","year":"2017","unstructured":"Malik S, Suchal K, Khan SI, Bhatia J, Kishore K, Dinda AK, Arya DS (2017) Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-\u0138B-TNF-\u03b1 and TGF-\u03b21-MAPK-fibronectin pathways. Am J Physiol Renal Physiol 313:F414\u2013F422. https:\/\/doi.org\/10.1152\/ajprenal.00393.2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"1555_CR118","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1681\/asn.2009060593","volume":"21","author":"JF Mann","year":"2010","unstructured":"Mann JF, Green D, Jamerson K, Ruilope LM, Kuranoff SJ, Littke T, Viberti G, ASCEND Study Group (2010) Avosentan for overt diabetic nephropathy. J Am Soc Nephrol 21:527\u2013535. https:\/\/doi.org\/10.1681\/asn.2009060593","journal-title":"J Am Soc Nephrol"},{"key":"1555_CR119","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/HJH.0b013e32835bf7b0","volume":"31","author":"JF Mann","year":"2013","unstructured":"Mann JF, Anderson C, Gao P, Gerstein HC, Boehm M, Ryden L, Sleight P, Teo KK, Yusuf S, ONTARGET investigators (2013) Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial. J Hypertens 31:414\u2013421. https:\/\/doi.org\/10.1097\/HJH.0b013e32835bf7b0","journal-title":"J Hypertens"},{"key":"1555_CR120","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1056\/nejmoa1616011","volume":"377","author":"JF Mann","year":"2017","unstructured":"Mann JF, \u00d8rsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Torn\u00f8e K, Zinman B, Buse JB (2017) Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med 377:839\u2013848. https:\/\/doi.org\/10.1056\/nejmoa1616011","journal-title":"N Engl J Med"},{"key":"1555_CR121","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature02664","volume":"430","author":"S Mariathasan","year":"2004","unstructured":"Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, Roose-Girma M, Erickson S, Dixit VM (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213\u2013218. https:\/\/doi.org\/10.1038\/nature02664","journal-title":"Nature"},{"key":"1555_CR122","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/nejmoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V (2016) Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 375:1834\u20131844. https:\/\/doi.org\/10.1056\/nejmoa1607141","journal-title":"N Engl J Med"},{"key":"1555_CR123","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1359-6101(98)00024-0","volume":"10","author":"A Meager","year":"1999","unstructured":"Meager A (1999) Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev 10:27\u201339","journal-title":"Cytokine Growth Factor Rev"},{"key":"1555_CR124","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fphys.2015.00082","volume":"6","author":"XM Meng","year":"2015","unstructured":"Meng XM, Tang PM, Li J, Lan HY (2015) TGF-\u00df\/Smad signaling in renal fibrosis. Front Physiol 6:82. https:\/\/doi.org\/10.3389\/fphys.2015.00082","journal-title":"Front Physiol"},{"key":"1555_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155296","volume":"124","author":"L Miao","year":"2024","unstructured":"Miao L, Zhang X, Zhang H, Cheong MS, Chen X, Farag MA, San Cheang W, Xiao J (2024) Baicalin ameliorates insulin resistance and regulates hepatic glucose metabolism via activating insulin signaling pathway in obese pre-diabetic mice. Phytomed 124:155296. https:\/\/doi.org\/10.1016\/j.phymed.2023.155296","journal-title":"Phytomed"},{"key":"1555_CR126","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1136\/bmj.321.7274.1440","volume":"321","author":"CE Mogensen","year":"2000","unstructured":"Mogensen CE, Neldam S, Tikkanen I, Oren S, Viskoper R, Watts RW, Cooper ME (2000) Randomised controlled trial of dual blockade of the renin-angiotensin system in patients with hypertension, microalbuminuria and non-insulin-dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 321:1440\u20131444. https:\/\/doi.org\/10.1136\/bmj.321.7274.1440","journal-title":"BMJ"},{"key":"1555_CR127","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1113\/jphysiol.2014.272328","volume":"592","author":"C Mora-Fern\u00e1ndez","year":"2014","unstructured":"Mora-Fern\u00e1ndez C, Dom\u00ednguez-Pimentel V, de Fuentes MM, G\u00f3rriz JL, Mart\u00ednez-Castelao A, Navarro-Gonz\u00e1lez JF (2014) Diabetic kidney disease: from physiology to therapeutics. J Physiol 592:3997\u20134012. https:\/\/doi.org\/10.1113\/jphysiol.2014.272328","journal-title":"J Physiol"},{"key":"1555_CR128","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1053\/meta.2003.50096","volume":"52","author":"Y Moriwaki","year":"2003","unstructured":"Moriwaki Y, Yamamoto T, Shibutani Y, Aoki E, Tsutsumi Z, Takahashi S, Okamura H, Koga M, Fukuchi M, Hada T (2003) Elevated levels of interleukin-18 and tumor necrosis factor-\u03b1 in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 52:605\u2013608. https:\/\/doi.org\/10.1053\/meta.2003.50096","journal-title":"Metabolism"},{"key":"1555_CR129","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2337\/dc16-0621","volume":"40","author":"O Mosenzon","year":"2017","unstructured":"Mosenzon O, Leibowitz G, Bhatt DL, Cahn A, Hirshberg B, Wei C, Im K, Rozenberg A, Yanuv I, Stahre C, Ray KK (2017) Effect of saxagliptin on renal outcomes in the SAVOR-TIMI 53 trial. Diabetes Care 40:69\u201376. https:\/\/doi.org\/10.2337\/dc16-0621","journal-title":"Diabetes Care"},{"key":"1555_CR130","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2174\/1570180819666220922103109","volume":"21","author":"MT Muhammed","year":"2024","unstructured":"Muhammed MT, Yalcin EA (2024) Molecular docking: Principles, advances, and its applications in drug discovery. Lett Drug des Discov 21:480\u2013495","journal-title":"Lett Drug des Discov"},{"key":"1555_CR131","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11101-016-9489-6","volume":"16","author":"PK Mukherjee","year":"2017","unstructured":"Mukherjee PK, Bahadur S, Harwansh RK, Biswas S, Banerjee S (2017) Paradigm shift in natural product research: traditional medicine inspired approaches. Phytochem Rev 16:803\u2013826. https:\/\/doi.org\/10.1007\/s11101-016-9489-6","journal-title":"Phytochem Rev"},{"key":"1555_CR132","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4062\/biomolther.2020.204","volume":"29","author":"V Natesan","year":"2021","unstructured":"Natesan V, Kim SJ (2021) Diabetic nephropathy\u2014a review of risk factors, progression, mechanism and dietary management. Biomol Ther (Seoul) 29:365. https:\/\/doi.org\/10.4062\/biomolther.2020.204","journal-title":"Biomol Ther (Seoul)"},{"key":"1555_CR133","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0272-6386(03)00408-6","volume":"42","author":"JF Navarro","year":"2003","unstructured":"Navarro JF, Mora C, Mac\u0131\u00e9a M, Garc\u0131\u00e9a J (2003) Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 42:53\u201361. https:\/\/doi.org\/10.1016\/S0272-6386(03)00408-6","journal-title":"Am J Kidney Dis"},{"key":"1555_CR134","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrneph.2011.51","volume":"7","author":"JF Navarro-Gonz\u00e1lez","year":"2011","unstructured":"Navarro-Gonz\u00e1lez JF, Mora-Fern\u00e1ndez C, De Fuentes MM, Garc\u00eda-P\u00e9rez J (2011a) Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 7:327\u2013340. https:\/\/doi.org\/10.1038\/nrneph.2011.51","journal-title":"Nat Rev Nephrol"},{"key":"1555_CR135","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jdiacomp.2010.09.003","volume":"25","author":"JF Navarro-Gonz\u00e1lez","year":"2011","unstructured":"Navarro-Gonz\u00e1lez JF, Muros M, Mora-Fern\u00e1ndez C, Herrera H, Meneses B, Garc\u00eda J (2011b) Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results. J Diabetes Complicat 25:314\u2013319","journal-title":"J Diabetes Complicat"},{"key":"1555_CR136","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejphar.2015.04.017","volume":"760","author":"WJ Ni","year":"2015","unstructured":"Ni WJ, Ding HH, Tang LQ (2015) Berberine as a promising anti-diabetic nephropathy drug: an analysis of its effects and mechanisms. Eur J Pharmacol 760:103\u2013112. https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.017","journal-title":"Eur J Pharmacol"},{"key":"1555_CR137","doi-asserted-by":"publisher","first-page":"9674","DOI":"10.1038\/s41598-023-33792-x","volume":"13","author":"P Niu","year":"2023","unstructured":"Niu P, Liu F, Lei F, Peng J, Wang Y, Zhao J, Gao Z, Gao Q, Gu J (2023) Breviscapine regulates the proliferation, migration, invasion, and apoptosis of colorectal cancer cells via the PI3K\/AKT pathway. Sci Rep 13:9674. https:\/\/doi.org\/10.1038\/s41598-023-33792-x","journal-title":"Sci Rep"},{"key":"1555_CR138","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/ptr","volume":"20","author":"JA Ojewole","year":"2006","unstructured":"Ojewole JA (2006) Analgesic, Antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats. Phytother Res 20:764\u2013772. https:\/\/doi.org\/10.1002\/ptr","journal-title":"Phytother Res"},{"key":"1555_CR139","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.2337\/diabetes.52.10.2586","volume":"52","author":"S Okada","year":"2003","unstructured":"Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, Wada J, Shikata Y, Makino H (2003) Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52:2586\u20132593. https:\/\/doi.org\/10.2337\/diabetes.52.10.2586","journal-title":"Diabetes"},{"key":"1555_CR140","doi-asserted-by":"publisher","first-page":"1000332","DOI":"10.4172\/2155-9600.1000332","volume":"5","author":"SM Osman","year":"2014","unstructured":"Osman SM, Hussein MA (2014) Purslane seeds fixed oil as a functional food in treatment of obesity induced by high fat diet in obese diabetic mice. J Nutr Food Sci 5:1000332. https:\/\/doi.org\/10.4172\/2155-9600.1000332","journal-title":"J Nutr Food Sci"},{"key":"1555_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107220","volume":"9","author":"PB Pal","year":"2014","unstructured":"Pal PB, Sinha K, Sil PC (2014) Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress-mediated signaling cascade, TNF\u03b1 related and mitochondrial-dependent apoptotic pathways in streptozotocin-induced diabetic rats. PLoS ONE 9:107220","journal-title":"PLoS ONE"},{"key":"1555_CR142","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.bbadis.2011.03.008","volume":"1812","author":"P Palsamy","year":"2011","unstructured":"Palsamy P, Subramanian S (2011) Resveratrol protects diabetic kidneys by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta Mol Basis Dis 1812:719\u2013731. https:\/\/doi.org\/10.1016\/j.bbadis.2011.03.008","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1555_CR143","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/j.1476-5381.2012.01854.x","volume":"166","author":"Y Pan","year":"2012","unstructured":"Pan Y, Wang Y, Cai L, Cai Y, Hu J, Yu C, Li J, Feng Z, Yang S, Li X, Liang G (2012) Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats. Br J Pharmacol 166:1169\u20131182. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01854.x","journal-title":"Br J Pharmacol"},{"key":"1555_CR144","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1055\/s-0034-1395658","volume":"123","author":"Y Pan","year":"2015","unstructured":"Pan Y, Qiao QY, Pan LH, Zhou DC, Hu C, Gu HF, Fu SK, Liu XL, Jin HM (2015) Losartan reduces insulin resistance by inhibiting oxidative stress and enhancing insulin signaling transduction. Exp Clin Endocrinol and Diabetes 123:170\u2013177. https:\/\/doi.org\/10.1055\/s-0034-1395658","journal-title":"Exp Clin Endocrinol and Diabetes"},{"key":"1555_CR145","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.phrs.2018.09.012","volume":"136","author":"N Parsamanesh","year":"2018","unstructured":"Parsamanesh N, Moossavi M, Bahrami A, Butler AE, Sahebkar A (2018) Therapeutic potential of curcumin in diabetic complications. Pharmacol Res 136:181\u2013193. https:\/\/doi.org\/10.1016\/j.phrs.2018.09.012","journal-title":"Pharmacol Res"},{"key":"1555_CR146","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.phymed.2017.12.018","volume":"39","author":"A Parveen","year":"2018","unstructured":"Parveen A, Jin M, Kim SY (2018) Bioactive phytochemicals that regulate the cellular processes involved in diabetic nephropathy. Phytomed 39:146\u2013159. https:\/\/doi.org\/10.1016\/j.phymed.2017.12.018","journal-title":"Phytomed"},{"key":"1555_CR147","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S1734-1140(09)70111-2","volume":"61","author":"S Patel","year":"2009","unstructured":"Patel S, Santani D (2009) Role of NF-\u03baB in the pathogenesis of diabetes and its associated complications. Pharmacol Report 61:595\u2013603. https:\/\/doi.org\/10.1016\/S1734-1140(09)70111-2","journal-title":"Pharmacol Report"},{"key":"1555_CR148","doi-asserted-by":"publisher","first-page":"55063","DOI":"10.5812\/jjnpp.55063","volume":"14","author":"SA Payami","year":"2019","unstructured":"Payami SA, Babaahmadi-Rezaei H, Ghaffari MA, Mansouri E, Mohammadzadeh G (2019) Hydroalcoholic extract of Zingiber officinale improves STZ-Induced diabetic nephropathy in rats by reduction of NF-\u03baB activation. Jundishapur J Nat Pharm Prod 14:55063. https:\/\/doi.org\/10.5812\/jjnpp.55063","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"1555_CR149","first-page":"92","volume":"5","author":"N Peter","year":"2017","unstructured":"Peter N, Majumdar J, Biswas G, Pawar HS, Mitra A, Mitra A (2017) Effects of mangiferin isolated from Mangifera indica leaves and evaluation of biologic activities of \u03b2-cyclodextrin-mangiferin complex particularly its anti-diabetic and hypolipidaemic properties on Type 1 diabetes rat model. Int J Herb Med 5:92\u201398","journal-title":"Int J Herb Med"},{"key":"1555_CR150","first-page":"141","volume":"6","author":"S Prabha Singh","year":"2019","unstructured":"Prabha Singh S, Sharma P, Kumar P, Mathur A, Mahapatra T, Professor A (2019) Role of cytokines IL-1, IL-6 and TNF-\u03b1 in the pathogenesis of diabetic nephropathy. Int Arch Integr Med 6:141\u2013150","journal-title":"Int Arch Integr Med"},{"key":"1555_CR151","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1039\/c9fo02398d","volume":"11","author":"MY Qi","year":"2020","unstructured":"Qi MY, Wang XT, Xu HL, Yang ZL, Cheng Y, Zhou B (2020) Protective effect of ferulic acid on STZ-induced diabetic nephropathy in rats. Food Funct 11:3706\u20133718. https:\/\/doi.org\/10.1039\/c9fo02398d","journal-title":"Food Funct"},{"key":"1555_CR152","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1039\/d0fo02335c","volume":"12","author":"MY Qi","year":"2021","unstructured":"Qi MY, He YH, Cheng Y, Fang Q, Ma RY, Zhou SJ, Hao JQ (2021) Icariin ameliorates streptozocin-induced diabetic nephropathy through suppressing the TLR4\/NF-\u03baB signal pathway. Food Funct 12:1241\u20131251. https:\/\/doi.org\/10.1039\/d0fo02335c","journal-title":"Food Funct"},{"key":"1555_CR153","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3892\/br.2016.636","volume":"4","author":"S Qiu","year":"2016","unstructured":"Qiu S, Sun G, Zhang Y, Li X, Wang R (2016) Involvement of the NF-\u03baB signaling pathway in the renoprotective effects of isorhamnetin in a type 2 diabetic rat model. Biomed Rep 4:628\u2013634. https:\/\/doi.org\/10.3892\/br.2016.636","journal-title":"Biomed Rep"},{"key":"1555_CR154","doi-asserted-by":"publisher","first-page":"3931043","DOI":"10.1155\/2023\/3931043","volume":"1","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, Tang J, Zhao Q, Jiang Y, Liu YN, Liu WJ (2023) From diabetic nephropathy to end-stage renal disease: the effect of chemokines on the immune system. J Diabetes Res 1:3931043. https:\/\/doi.org\/10.1155\/2023\/3931043","journal-title":"J Diabetes Res"},{"key":"1555_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116633","volume":"475","author":"Y Quan","year":"2023","unstructured":"Quan Y, Su P, Shangguan C, Hao H, Yue L, Chen C (2023) Bergenin ameliorates diabetic nephropathy in C57BL\/6 J mice by TLR4\/MyD88\/NF-\u03baB signalling pathway regulation. Toxicol Appl Pharmacol 475:116633. https:\/\/doi.org\/10.1016\/j.taap.2023.116633","journal-title":"Toxicol Appl Pharmacol"},{"key":"1555_CR156","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3390\/antiox12051052","volume":"12","author":"C Ram","year":"2023","unstructured":"Ram C, Gairola S, Verma S, Mugale MN, Bonam SR, Murty US, Sahu BD (2023) Biochanin A ameliorates nephropathy in high-fat diet\/streptozotocin-induced diabetic rats: effects on NF-\u03baB\/NLRP3 axis. Pyroptosis Fibrosis Antioxidants 12:1052. https:\/\/doi.org\/10.3390\/antiox12051052","journal-title":"Pyroptosis Fibrosis Antioxidants"},{"key":"1555_CR157","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.3390\/ijms21113798","volume":"21","author":"S Rayego-Mateos","year":"2020","unstructured":"Rayego-Mateos S, Morgado-Pascual JL, Opazo-R\u00edos L, Guerrero-Hue M, Garc\u00eda-Caballero C, V\u00e1zquez-Carballo C, Mas S, Sanz AB, Herencia C, Mezzano S, G\u00f3mez-Guerrero C (2020) Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy. Int J Mol Sci 21:3798. https:\/\/doi.org\/10.3390\/ijms21113798","journal-title":"Int J Mol Sci"},{"key":"1555_CR158","doi-asserted-by":"publisher","first-page":"110507","DOI":"10.1016\/j.cbi.2023.110507","volume":"380","author":"RN Razliqi","year":"2023","unstructured":"Razliqi RN, Ahangarpour A, Mard SA, Khorsandi L (2023) Gentisic acid protects against diabetic nephropathy in nicotinamide-streptozotocin administered male mice by attenuating oxidative stress and inflammation: The role of miR-200a\/Keap1\/Nrf2 pathway, renin-angiotensin system (RAS) and NF-\u043aB. Chem Biol Interact 380:110507. https:\/\/doi.org\/10.1016\/j.cbi.2023.110507","journal-title":"Chem Biol Interact"},{"key":"1555_CR159","doi-asserted-by":"publisher","first-page":"1335094","DOI":"10.3389\/fphar.2023.1335094","volume":"14","author":"N Ren","year":"2023","unstructured":"Ren N, Wang WF, Zou L, Zhao YL, Miao H, Zhao YY (2023) The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis. Front Pharmacol 14:1335094. https:\/\/doi.org\/10.3389\/fphar.2023.1335094","journal-title":"Front Pharmacol"},{"key":"1555_CR160","doi-asserted-by":"publisher","first-page":"29871","DOI":"10.1016\/j.heliyon.2024.e29871","volume":"10","author":"A Rezaee","year":"2024","unstructured":"Rezaee A, Rahmanian P, Nemati A, Sohrabifard F, Karimi F, Elahinia A, Ranjbarpazuki A, Lashkarbolouki R, Dezfulian S, Zandieh MA, Salimimoghadam S (2024) NF-\u0138B axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies. Heliyon 10:29871. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29871","journal-title":"Heliyon"},{"key":"1555_CR161","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.2215\/CJN.16201020","volume":"15","author":"P Rossing","year":"2020","unstructured":"Rossing P (2020) Mineralocorticoid receptor antagonists for diabetic kidney disease. Clin J Am Soc Nephrol 15:1696\u20131698. https:\/\/doi.org\/10.2215\/CJN.16201020","journal-title":"Clin J Am Soc Nephrol"},{"key":"1555_CR162","doi-asserted-by":"publisher","first-page":"888","DOI":"10.2337\/dc22-0294","volume":"45","author":"P Rossing","year":"2022","unstructured":"Rossing P, Burgess E, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Gillard P, MacIsaac RJ, Wainstein J, Joseph A (2022) Finerenone in patients with chronic kidney disease and type 2 diabetes according to baseline HbA1c and insulin use: an analysis from the FIDELIO-DKD study. Diabetes Care 45:888\u2013897. https:\/\/doi.org\/10.2337\/dc22-0294","journal-title":"Diabetes Care"},{"key":"1555_CR163","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1159\/000371497","volume":"40","author":"LM Ruilope","year":"2015","unstructured":"Ruilope LM, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Ferreira AC (2015) Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess t safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy. Am J Nephrol 40:572\u2013581. https:\/\/doi.org\/10.1159\/000371497","journal-title":"Am J Nephrol"},{"key":"1555_CR164","doi-asserted-by":"publisher","first-page":"24","DOI":"10.51847\/Une9jqjUCl","volume":"13","author":"MK Sahu","year":"2024","unstructured":"Sahu MK, Nayak AK, Hailemeskel B, Eyupoglu OE (2024) Exploring recent updates on molecular docking: types, methods, applications, limitations and future prospects. Int J Pharm Res Allied Sci 13:24\u201340","journal-title":"Int J Pharm Res Allied Sci"},{"key":"1555_CR165","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.lfs.2016.06.002","volume":"157","author":"YA Samra","year":"2016","unstructured":"Samra YA, Said HS, Elsherbiny NM, Liou GI, El-Shishtawy MM, Eissa LA (2016) Cepharanthine and piperine ameliorate diabetic nephropathy in rats: role of NF-\u03baB and NLRP3 inflammasome. Life Sci 157:187\u2013199. https:\/\/doi.org\/10.1016\/j.lfs.2016.06.002","journal-title":"Life Sci"},{"key":"1555_CR166","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1497449","author":"N Samsu","year":"2021","unstructured":"Samsu N (2021) Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int. https:\/\/doi.org\/10.1155\/2021\/1497449","journal-title":"Biomed Res Int"},{"key":"1555_CR167","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1681\/ASN.2010020218","volume":"21","author":"AB Sanz","year":"2010","unstructured":"Sanz AB, Sanchez-Ni\u00f1o MD, Ramos AM, Moreno JA, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A (2010) NF-\u03baB in renal inflammation. J Am Soc Nephrol 21:1254\u20131262. https:\/\/doi.org\/10.1681\/ASN.2010020218","journal-title":"J Am Soc Nephrol"},{"key":"1555_CR168","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00125-008-1184","volume":"52","author":"KJ Schjoedt","year":"2009","unstructured":"Schjoedt KJ, Astrup AS, Persson F, Frandsen E, Boomsma F, Rossing K, Tarnow L, Rossing P, Parving HH (2009) Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial. Diabetologia 52:46\u201349. https:\/\/doi.org\/10.1007\/s00125-008-1184","journal-title":"Diabetologia"},{"key":"1555_CR169","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14007","volume":"22","author":"NM Selby","year":"2020","unstructured":"Selby NM, Taal MW (2020) An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab 22:3\u201315. https:\/\/doi.org\/10.1111\/dom.14007","journal-title":"Diabetes Obes Metab"},{"key":"1555_CR170","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.phrs.2017.11.030","volume":"129","author":"EJ Seo","year":"2018","unstructured":"Seo EJ, Fischer N, Efferth T (2018) Phytochemicals as inhibitors of NF-\u03baB for treatment of Alzheimer\u2019s disease. Pharmacol Res 129:262\u2013273","journal-title":"Pharmacol Res"},{"key":"1555_CR171","doi-asserted-by":"publisher","first-page":"368","DOI":"10.22205\/sijbs\/2016\/v2\/i4\/103443","volume":"2","author":"M Serasanambati","year":"2016","unstructured":"Serasanambati M, Chilakapati SR (2016) Function of nuclear factor kappa B (NF-\u03baB) in human diseases-a review. South Indian J Biol Sci 2:368. https:\/\/doi.org\/10.22205\/sijbs\/2016\/v2\/i4\/103443","journal-title":"South Indian J Biol Sci"},{"key":"1555_CR172","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/ndt\/6.12.917","volume":"6","author":"D Seron","year":"1991","unstructured":"Seron D, Cameron JS, Haskard DO (1991) Nephrology dialysis transplantation expression of vcam-1 in the normal and diseased kidney. Nephrol Dial Transplant 6:917\u2013922. https:\/\/doi.org\/10.1093\/ndt\/6.12.917","journal-title":"Nephrol Dial Transplant"},{"key":"1555_CR173","doi-asserted-by":"publisher","first-page":"3268136","DOI":"10.1155\/2021\/3268136","volume":"1","author":"J Sharifi-Rad","year":"2021","unstructured":"Sharifi-Rad J, Quispe C, Imran M, Rauf A, Nadeem M, Gondal TA, Ahmad B, Atif M, Mubarak MS, Sytar O, Zhilina OM (2021) Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits. Oxid Med Cell Longev 1:3268136. https:\/\/doi.org\/10.1155\/2021\/3268136","journal-title":"Oxid Med Cell Longev"},{"key":"1555_CR174","first-page":"3053","volume":"20","author":"N Sharma","year":"2020","unstructured":"Sharma N, Tiwari N, Vyas M, Khurana N, Muthuraman A, Utreja P (2020) An overview of therapeutic effects of vanillic acid. Plant Arch 20:3053\u20133059","journal-title":"Plant Arch"},{"key":"1555_CR175","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/jphp.12931","volume":"70","author":"R Shukla","year":"2018","unstructured":"Shukla R, Banerjee S, Tripathi YB (2018) Pueraria tuberosa extract inhibits iNOS and IL-6 through suppression of PKC-\u03b1 and NF-\u03baB pathway in diabetes-induced nephropathy. J Pharm Pharmacol 70:1102\u20131112. https:\/\/doi.org\/10.1111\/jphp.12931","journal-title":"J Pharm Pharmacol"},{"key":"1555_CR176","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.lfs.2010.11.020","volume":"88","author":"HR Siddique","year":"2011","unstructured":"Siddique HR, Saleem M (2011) Beneficial health effects of lupeol triterpene: a review of preclinical studies. Life Sci 88:285\u2013293. https:\/\/doi.org\/10.1016\/j.lfs.2010.11.020","journal-title":"Life Sci"},{"key":"1555_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104199","volume":"74","author":"B Singh","year":"2020","unstructured":"Singh B, Kumar A, Singh H, Kaur S, Kaur S, Buttar HS, Arora S, Singh B (2020) Zingerone produces antidiabetic effects and attenuates diabetic nephropathy by reducing oxidative stress and overexpression of NF-\u03baB, TNF-\u03b1, and COX-2 proteins in rats. J Funct Foods 74:104199. https:\/\/doi.org\/10.1016\/j.jff.2020.104199","journal-title":"J Funct Foods"},{"key":"1555_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-89775-4.00014-6","author":"S Singh","year":"2022","unstructured":"Singh S, Baker QB, Singh DB (2022) Molecular docking and molecular dynamics simulation. Bioinformatics. https:\/\/doi.org\/10.1016\/B978-0-323-89775-4.00014-6","journal-title":"Bioinformatics"},{"key":"1555_CR179","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1743-7075-8-35","volume":"8","author":"V Soetikno","year":"2011","unstructured":"Soetikno V, Sari FR, Veeraveedu PT, Thandavarayan RA, Harima M, Sukumaran V, Lakshmanan AP, Suzuki K, Kawachi H, Watanabe K (2011) Curcumin ameliorates macrophage infiltration by inhibiting NF-B activation and proinflammatory cytokines in streptozotocin-induced diabetic nephropathy. Nutr Metab 8:35. https:\/\/doi.org\/10.1186\/1743-7075-8-35","journal-title":"Nutr Metab"},{"key":"1555_CR180","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3389\/fimmu.2019.00815","volume":"10","author":"N Song","year":"2019","unstructured":"Song N, Thaiss F, Guo L (2019) NF-\u039ab and kidney injury. Front Immunol 10:815. https:\/\/doi.org\/10.3389\/fimmu.2019.00815","journal-title":"Front Immunol"},{"key":"1555_CR181","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","volume":"8","author":"H Su","year":"2017","unstructured":"Su H, Lei CT, Zhang C (2017) Interleukin-6 signaling pathway and its role in kidney disease: an update. Front Immunol 8:405. https:\/\/doi.org\/10.3389\/fimmu.2017.00405","journal-title":"Front Immunol"},{"key":"1555_CR182","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2010.177","volume":"21","author":"SC Sun","year":"2011","unstructured":"Sun SC (2011) Non-canonical NF-\u03baB signaling pathway. Cell Res 21:71\u201385. https:\/\/doi.org\/10.1038\/cr.2010.177","journal-title":"Cell Res"},{"key":"1555_CR183","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","volume":"17","author":"SC Sun","year":"2017","unstructured":"Sun SC (2017) The non-canonical NF-\u03baB pathway in immunity and inflammation. Nat Rev Immunol 17:545\u2013558. https:\/\/doi.org\/10.1038\/nri.2017.52","journal-title":"Nat Rev Immunol"},{"key":"1555_CR184","doi-asserted-by":"publisher","first-page":"14826","DOI":"10.7717\/peerj.14826","volume":"11","author":"L Sun","year":"2023","unstructured":"Sun L, Ding M, Chen F, Zhu D, Xie X (2023) Breviscapine alleviates podocyte injury by inhibiting NF-\u03baB\/NLRP3-mediated pyroptosis in diabetic nephropathy. Peer J 11:14826. https:\/\/doi.org\/10.7717\/peerj.14826","journal-title":"Peer J"},{"key":"1555_CR185","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fphar.2017.00798","volume":"8","author":"SV Suryavanshi","year":"2017","unstructured":"Suryavanshi SV, Kulkarni YA (2017) NF-\u03baB: A potential target in the management of vascular complications of diabetes. Front Pharmacol 8:798. https:\/\/doi.org\/10.3389\/fphar.2017.00798","journal-title":"Front Pharmacol"},{"key":"1555_CR186","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1038\/s41598-025-87319-7","volume":"15","author":"RU Syed","year":"2025","unstructured":"Syed RU, Moni SS, Hussein W, Alhaidan TM, Abumilha SM, Alnahdi LK, Wong LS, Subramaniyan V, Kumarasamy V (2025) Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-\u03b1\/NF-\u03baB\/TGF-\u03b2: in vivo and in silico study. Sci Rep 15:4369. https:\/\/doi.org\/10.1038\/s41598-025-87319-7","journal-title":"Sci Rep"},{"key":"1555_CR187","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/imj.16455","volume":"54","author":"S Templer","year":"2024","unstructured":"Templer S, Abdo S, Wong T (2024) Preventing diabetes complications. Intern Med J 54:1264\u20131274. https:\/\/doi.org\/10.1111\/imj.16455","journal-title":"Intern Med J"},{"key":"1555_CR188","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1002\/bmc.5838","volume":"38","author":"Z Tian","year":"2024","unstructured":"Tian Z, Zhang Y, Wang XZ, Cui XB, Li W, Tan XH, Chen JJ, Lin HZ, Wen HM (2024) Chemical profile and difference analysis of four parts of Strobilanthes sarcorrhiza by ultrafast flow liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry and multivariate statistical analysis. Biomed Chromatogr 38:5838. https:\/\/doi.org\/10.1002\/bmc.5838","journal-title":"Biomed Chromatogr"},{"key":"1555_CR189","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","volume":"1843","author":"MD Turner","year":"2014","unstructured":"Turner MD, Nedjai B, Hurst T, Pennington DJ (2014) Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta Mol Cell Res 1843:2563\u20132582. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.05.014","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1555_CR190","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/ard.2004.028266","volume":"63","author":"IM Verma","year":"2004","unstructured":"Verma IM (2004) Nuclear factor (NF)-\u03baB proteins: Therapeutic targets. Ann Rheum Dis 63:57\u201361. https:\/\/doi.org\/10.1136\/ard.2004.028266","journal-title":"Ann Rheum Dis"},{"key":"1555_CR191","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1161\/01.cir.0000024416.33113.0a","volume":"106","author":"G Viberti","year":"2002","unstructured":"Viberti G (2002) MicroAlbuminuria reduction with VALsartan (MARVAL) Study Investigators. Microalbuminuria reduction with valsartan in patients with type 2 diabetes Mellitus: a blood pressure-independent effect. Circulation 106:672\u2013678. https:\/\/doi.org\/10.1161\/01.cir.0000024416.33113.0a","journal-title":"Circulation"},{"key":"1555_CR192","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.mce.2016.06.019","volume":"434","author":"S Wang","year":"2016","unstructured":"Wang S, Yang Z, Xiong F, Chen C, Chao X, Huang J, Huang H (2016) Betulinic acid ameliorates experimental diabetic-induced renal inflammation and fibrosis via inhibiting the activation of NF-\u03baB signaling pathway. Mol Cell Endocrinol 434:135\u2013143. https:\/\/doi.org\/10.1016\/j.mce.2016.06.019","journal-title":"Mol Cell Endocrinol"},{"key":"1555_CR193","doi-asserted-by":"publisher","first-page":"3997190","DOI":"10.1155\/2022\/3997190","volume":"2022","author":"G Wang","year":"2022","unstructured":"Wang G, Wang Y, Yao L, Gu W, Zhao S, Shen Z, Lin Z, Liu W, Yan T (2022a) Pharmacological activity of quercetin: an updated review. Evid Based Complement Alternat Med 2022:3997190. https:\/\/doi.org\/10.1155\/2022\/3997190","journal-title":"Evid Based Complement Alternat Med"},{"key":"1555_CR194","doi-asserted-by":"publisher","first-page":"154251","DOI":"10.1016\/j.phymed.2022.154251","volume":"104","author":"M Wang","year":"2022","unstructured":"Wang M, Liu X, Wang Z, Xu Q (2022b) The extract of polygala fallax hemsl. Slows the progression of diabetic nephropathy by targeting TLR4 anti-inflammation and MMP-2\/9-mediated anti-fibrosis in vitro. Phytomedicine 104:154251. https:\/\/doi.org\/10.1016\/j.phymed.2022.154251","journal-title":"Phytomedicine"},{"key":"1555_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.953004","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang Z, Chen Z, Wang X, Hu Y, Kong J, Lai J, Li T, Hu B, Zhang Y, Zheng X, Liu X (2022c) Sappanone a prevents diabetic kidney disease by inhibiting kidney inflammation and fibrosis via the NF-\u03baB signaling pathway. Front Pharmacol 13:953004. https:\/\/doi.org\/10.3389\/fphar.2022.953004","journal-title":"Front Pharmacol"},{"key":"1555_CR237","doi-asserted-by":"publisher","unstructured":"Wang C, Wu R, Zhang S, Gong L, Fu K, Yao C, Peng C, Li Y (2023) A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives. Biomed. Pharmacother. 1:166:115410. https:\/\/doi.org\/10.1016\/j.biopha.2023.115410","DOI":"10.1016\/j.biopha.2023.115410"},{"key":"1555_CR196","doi-asserted-by":"publisher","first-page":"1432724","DOI":"10.3389\/fphar.2024.1432724","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang R, Wu C, Wang L, Liu P, Li P (2024a) Exploring potential targets for natural product therapy of DN: the role of SUMOylation. Front Pharmacol 15:1432724. https:\/\/doi.org\/10.3389\/fphar.2024.1432724","journal-title":"Front Pharmacol"},{"key":"1555_CR197","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41598-024-51150-3","volume":"14","author":"X Wang","year":"2024","unstructured":"Wang X, Liu M, Li X, Zhang M, Xu F, Liu H, Wu H (2024b) Utilizing molecular docking and cell validation to explore the potential mechanisms of lupenone attenuating the inflammatory response via NF-\u03baB pathway. Sci Rep 14:625. https:\/\/doi.org\/10.1038\/s41598-024-51150-3","journal-title":"Sci Rep"},{"key":"1555_CR198","doi-asserted-by":"publisher","first-page":"2400215","DOI":"10.1002\/mnfr.202400215","volume":"68","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yang J, Chang X, Xue Y, Liu G, Zhang T, Chen W, Fan W, Tian J, Ren X (2024c) Isoliquiritigenin alleviates diabetic kidney disease via oxidative stress and the TLR4\/NF-\u03baB\/NLRP3 inflammasome pathway. Mol Nutr Food Res 68:2400215. https:\/\/doi.org\/10.1002\/mnfr.202400215","journal-title":"Mol Nutr Food Res"},{"key":"1555_CR199","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/nejmoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B (2016) Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 375:323\u2013334. https:\/\/doi.org\/10.1056\/nejmoa1515920","journal-title":"N Engl J Med"},{"key":"1555_CR200","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/ijms24010570","volume":"24","author":"K Watanabe","year":"2022","unstructured":"Watanabe K, Sato E, Mishima E, Miyazaki M, Tanaka T (2022) What\u2019s new in the molecular mechanisms of diabetic kidney disease: recent advances. Int J Mol Sci 24:570. https:\/\/doi.org\/10.3390\/ijms24010570","journal-title":"Int J Mol Sci"},{"key":"1555_CR201","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/ndt\/gfaa234","volume":"35","author":"DC Wheeler","year":"2020","unstructured":"Wheeler DC, Stefansson BV, Batiushin M, Bilchenko O, Cherney DZ, Chertow GM, Douthat W, Dwyer JP, Escudero E, Pecoits-Filho R, Furuland H (2020) The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrol Dial Transplant 35:1700\u20131711. https:\/\/doi.org\/10.1093\/ndt\/gfaa234","journal-title":"Nephrol Dial Transplant"},{"key":"1555_CR202","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1681\/ASN.2007050556","volume":"19","author":"PP Wolkow","year":"2008","unstructured":"Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH, Krolewski AS (2008) Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol 19:789\u2013797. https:\/\/doi.org\/10.1681\/ASN.2007050556","journal-title":"J Am Soc Nephrol"},{"key":"1555_CR203","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.micpath.2018.02.024","volume":"117","author":"J Wu","year":"2018","unstructured":"Wu J, Ding Y, Wang J, Wang F (2018) Staphylococcus aureus induces TGF-\u03b21 and bFGF expression through the activation of AP-1 and NF-\u03baB transcription factors in bovine mammary epithelial cells. Microb Pathog 117:276\u2013284. https:\/\/doi.org\/10.1016\/j.micpath.2018.02.024","journal-title":"Microb Pathog"},{"key":"1555_CR204","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/horticulturae9070737","volume":"23","author":"C Wu","year":"2023","unstructured":"Wu C, Zhang X, Liu B, Tang H (2023a) Research progress on the medicinal and edible polygala fallax hemsl (polygalaceae) plant. Horticulturae 23:737","journal-title":"Horticulturae"},{"key":"1555_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154959","volume":"118","author":"H Wu","year":"2023","unstructured":"Wu H, Xu F, Huang X, Li X, Yu P, Zhang L, Yang X, Kong J, Zhen C, Wang X (2023b) Lupenone improves type 2 diabetic nephropathy by regulating NF-\u03baB pathway-mediated inflammation and TGF-\u03b21\/Smad\/CTGF-associated fibrosis. Phytomedicine 118:154959. https:\/\/doi.org\/10.1016\/j.phymed.2023.154959","journal-title":"Phytomedicine"},{"key":"1555_CR206","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12882-024-03563-5","volume":"25","author":"S Wu","year":"2024","unstructured":"Wu S, Wang H, Pan D, Guo J, Zhang F, Ning Y, Gu Y, Guo L (2024) Navigating the future of diabetes: innovative nomogram models for predicting all-cause mortality risk in diabetic nephropathy. BMC Nephrol 25:127. https:\/\/doi.org\/10.1186\/s12882-024-03563-5","journal-title":"BMC Nephrol"},{"key":"1555_CR207","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/s1097-2765(01)00187-3","volume":"7","author":"G Xiao","year":"2001","unstructured":"Xiao G, Harhaj EW, Sun SC (2001) NF-\u03baB-inducing kinase regulates the processing of NF-\u03baB2 p100. Mol Cell 7:401\u2013409. https:\/\/doi.org\/10.1016\/s1097-2765(01)00187-3","journal-title":"Mol Cell"},{"key":"1555_CR208","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1039\/c6fo01601d","volume":"8","author":"R Xie","year":"2017","unstructured":"Xie R, Zhang H, Wang XZ, Yang XZ, Wu SN, Wang HG, Shen P, Ma TH (2017) The protective effect of betulinic acid (BA) diabetic nephropathy on streptozotocin (STZ)-induced diabetic rats. Food Funct 8:299\u2013306. https:\/\/doi.org\/10.1039\/c6fo01601d","journal-title":"Food Funct"},{"key":"1555_CR209","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/289327","volume":"2014","author":"F Xu","year":"2014","unstructured":"Xu F, Wang Y, Cui W, Yuan H, Sun J, Wu M, Guo Q, Kong L, Wu H, Miao L (2014) Resveratrol prevention of diabetic nephropathy is associated with the suppression of renal inflammation and mesangial cell proliferation: Possible roles of Akt\/NF-\u03baB pathway. Int J Endocrinol 2014:289327. https:\/\/doi.org\/10.1155\/2014\/289327","journal-title":"Int J Endocrinol"},{"key":"1555_CR210","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/ptr.6966","volume":"35","author":"J Xu","year":"2021","unstructured":"Xu J, Wang Y, Wang Z, Guo L, Li X (2021) Fucoidan mitigated diabetic nephropathy through the downregulation of PKC and modulation of NF-\u03baB signaling pathway: in vitro and in vivo investigations. Phytother Res 35:2133\u20132144. https:\/\/doi.org\/10.1002\/ptr.6966","journal-title":"Phytother Res"},{"key":"1555_CR211","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/13813455.2021.1959617","volume":"130","author":"M Xu","year":"2024","unstructured":"Xu M, Wang R, Fan H, Ni Z (2024a) Nobiletin ameliorates streptozotocin-cadmium-induced diabetic nephropathy via NF-\u03baB signalling pathway in rats. Arch Physiol Biochem 130:29\u201337. https:\/\/doi.org\/10.1080\/13813455.2021.1959617","journal-title":"Arch Physiol Biochem"},{"key":"1555_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117356","volume":"319","author":"Z Xu","year":"2024","unstructured":"Xu Z, Cai K, Su SL, Zhu Y, Liu F, Duan J (2024b) Salvianolic acid B and tanshinone IIA synergistically improve early diabetic nephropathy through regulating PI3K\/Akt\/NF-\u03baB signaling pathway. J Ethnopharmacol 319:117356. https:\/\/doi.org\/10.1016\/j.jep.2023.117356","journal-title":"J Ethnopharmacol"},{"key":"1555_CR213","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2147\/IJNRD.S436791","volume":"16","author":"R Xue","year":"2023","unstructured":"Xue R, Xiao H, Kumar V, Lan X, Malhotra A, Singhal PC, Chen J (2023) The molecular mechanism of renal tubulointerstitial inflammation promoting diabetic nephropathy. Int J Nephrol Renovasc Dis 16:241\u2013252. https:\/\/doi.org\/10.2147\/IJNRD.S436791","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"1555_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117058","volume":"177","author":"JP Yadav","year":"2024","unstructured":"Yadav JP, Verma A, Pathak P, Dwivedi AR, Singh AK, Kumar P, Khalilullah H, Jaremko M, Emwas AH, Patel DK (2024) Phytoconstituents as modulators of NF-\u03baB signalling: Investigating therapeutic potential for diabetic wound healing. Biomed Pharmacother 177:117058. https:\/\/doi.org\/10.1016\/j.biopha.2024.117058","journal-title":"Biomed Pharmacother"},{"key":"1555_CR215","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/biology13120984","volume":"13","author":"MA Yahya","year":"2024","unstructured":"Yahya MA, Alshammari GM, Osman MA, Al-Harbi LN, Alotaibi SN (2024) Isoliquiritigenin prevents the development of nephropathy by an HFD in rats through the induction of antioxidant production and inhibition of the MD-2\/TLR4\/NF-\u03baB pathway. Biology (Basel) 13:984. https:\/\/doi.org\/10.3390\/biology13120984","journal-title":"Biology (Basel)"},{"key":"1555_CR216","doi-asserted-by":"publisher","DOI":"10.1177\/09603271221143713","author":"F Yang","year":"2022","unstructured":"Yang F, Zhang Z, Zhang L (2022) Bisacurone attenuates diabetic nephropathy by ameliorating oxidative stress, inflammation and apoptosis in rats. Hum Exp Toxicol. https:\/\/doi.org\/10.1177\/09603271221143713","journal-title":"Hum Exp Toxicol"},{"key":"1555_CR217","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12013-024-01559-4","volume":"19","author":"S Yang","year":"2024","unstructured":"Yang S, Zhang Y, Zheng C (2024) \u03b2-Sitosterol mitigates apoptosis, oxidative stress and inflammatory response by inactivating TLR4\/NF-\u043aB pathway in cell models of diabetic nephropathy. Cell Biochem Biophys 19:1\u20134. https:\/\/doi.org\/10.1007\/s12013-024-01559-4","journal-title":"Cell Biochem Biophys"},{"key":"1555_CR218","doi-asserted-by":"publisher","first-page":"1117489","DOI":"10.3389\/fendo.2023.1117489","volume":"14","author":"Y Ye","year":"2023","unstructured":"Ye Y, Zhou J (2023) The protective activity of natural flavonoids against osteoarthritis by targeting NF-\u03baB signaling pathway. Front Endocrinol 14:1117489. https:\/\/doi.org\/10.3389\/fendo.2023.1117489","journal-title":"Front Endocrinol"},{"key":"1555_CR219","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.2147\/DDDT.S96435","volume":"9","author":"YL Yuan","year":"2015","unstructured":"Yuan YL, Guo CR, Cui LL, Ruan SX, Zhang CF, Ji D, Yang ZL, Li F (2015) Timosaponin B-II ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-\u03baB signaling pathways in alloxan-induced mice. Drug des Devel Ther 9:6247\u20136258. https:\/\/doi.org\/10.2147\/DDDT.S96435","journal-title":"Drug des Devel Ther"},{"key":"1555_CR220","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C (2022) Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther 7:182. https:\/\/doi.org\/10.1038\/s41392-022-01036-5","journal-title":"Signal Transduct Target Ther"},{"key":"1555_CR221","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.3390\/molecules27154922","volume":"27","author":"Q Yue","year":"2022","unstructured":"Yue Q, Song Y, Liu Z, Zhang L, Yang L, Li J (2022) Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases. Molecules 27:4922. https:\/\/doi.org\/10.3390\/molecules27154922","journal-title":"Molecules"},{"key":"1555_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117088","volume":"239","author":"IE Zabad","year":"2019","unstructured":"Zabad IE, Amin MN, El-Shishtawy MM (2019) Protective effect of vanillin on diabetic nephropathy by decreasing advanced glycation end products in rats. Life Sci 239:117083. https:\/\/doi.org\/10.1016\/j.lfs.2019.117088","journal-title":"Life Sci"},{"key":"1555_CR223","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.brainresbull.2018.08.021","volume":"142","author":"L Zhang","year":"2018","unstructured":"Zhang L, Previn R, Lu L, Liao RF, Jin Y, Wang RK (2018) Crocin, a natural product attenuates lipopolysaccharide-induced anxiety and depressive-like behaviours through suppressing NF-\u03baB and NLRP3 signaling pathway. Brain Res Bull 142:352\u2013359. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.08.021","journal-title":"Brain Res Bull"},{"key":"1555_CR224","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/ptr.6314","volume":"33","author":"M Zhang","year":"2019","unstructured":"Zhang M, Chen Y, Yang MJ, Fan XR, Xie H, Zhang L, Nie YS, Yan M (2019a) Celastrol attenuates renal injury in diabetic rats via MAPK\/NF-\u03baB pathway. Phytother Res 33:1191\u20131198. https:\/\/doi.org\/10.1002\/ptr.6314","journal-title":"Phytother Res"},{"key":"1555_CR225","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.12659\/MSM.915242","volume":"25","author":"YY Zhang","year":"2019","unstructured":"Zhang YY, Tan RZ, Zhang XQ, Yu Y, Yu C (2019b) Calycosin ameliorates diabetes-induced renal inflammation via the NF-\u03baB pathway in vitro and in vivo. Med Sci MoMiao Nit 25:1671\u20131678. https:\/\/doi.org\/10.12659\/MSM.915242","journal-title":"Med Sci MoMiao Nit"},{"key":"1555_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106967","volume":"88","author":"R Zhang","year":"2020","unstructured":"Zhang R, Lu M, Zhang S, Liu J (2020) Renoprotective effects of Tilianin in diabetic rats through modulation of oxidative stress via Nrf2-Keap1 pathway and inflammation via TLR4\/MAPK\/NF-\u03baB pathways. Int Immunopharmacol 88:106967. https:\/\/doi.org\/10.1016\/j.intimp.2020.106967","journal-title":"Int Immunopharmacol"},{"key":"1555_CR227","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12906-023-04330-z","volume":"24","author":"WM Zhao","year":"2024","unstructured":"Zhao WM, Li XL, Zhu Y, Shi R, Wang ZJ, Xiao JP, Wang DG (2024) Diosmin ameliorates renal fibrosis through inhibition of inflammation by regulating SIRT3-mediated NF-\u03baB p65 nuclear translocation. BMC Complement Med Ther 24:29. https:\/\/doi.org\/10.1186\/s12906-023-04330-z","journal-title":"BMC Complement Med Ther"},{"key":"1555_CR228","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/cr.2010.171","volume":"21","author":"C Zheng","year":"2011","unstructured":"Zheng C, Yin Q, Wu H (2011) Structural studies of NF-\u03baB signaling. Cell Res 21:183\u2013195. https:\/\/doi.org\/10.1038\/cr.2010.171","journal-title":"Cell Res"},{"key":"1555_CR229","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.toxlet.2013.03.001","volume":"219","author":"N Zheng","year":"2013","unstructured":"Zheng N, Lin X, Wen Q, Zhang S, Huang J, Xu X, Huang R (2013) Effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation end-product-mediated renal injury in type 2 diabetic KKAy mice. Toxicol Lett 219:77\u201384. https:\/\/doi.org\/10.1016\/j.toxlet.2013.03.001","journal-title":"Toxicol Lett"},{"key":"1555_CR230","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.2147\/DDDT.S274256","volume":"14","author":"ZC Zheng","year":"2020","unstructured":"Zheng ZC, Zhu W, Lei L, Liu XQ, Wu YG (2020) Wogonin ameliorates renal inflammation and fibrosis by inhibiting NF-\u03baB and TGF-\u03b21\/Smad3 signaling pathways in diabetic nephropathy. Drug des Devel Ther 14:4135\u20134148. https:\/\/doi.org\/10.2147\/DDDT.S274256","journal-title":"Drug des Devel Ther"},{"key":"1555_CR231","first-page":"475","volume":"35","author":"YC Zhong","year":"2012","unstructured":"Zhong YC (2012) Study on the extraction technology and hypoglycemic activity of lectin from Trichosanthes kirilowi. J Chin Med Mater 35:475\u2013479","journal-title":"J Chin Med Mater"},{"key":"1555_CR232","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/bbb\/zbab012","volume":"85","author":"G Zhou","year":"2021","unstructured":"Zhou G, Cui J, Xie S (2021) Vitexin, a fenugreek glycoside, ameliorated obesity-induced diabetic nephropathy via modulation of NF-\u03baB\/IkB\u03b1 and AMPK\/ACC pathways in mice. Biosci Biotechnol Biochem 85:1183\u20131193. https:\/\/doi.org\/10.1093\/bbb\/zbab012","journal-title":"Biosci Biotechnol Biochem"},{"key":"1555_CR233","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40659-018-0157-8","volume":"51","author":"L Zhu","year":"2018","unstructured":"Zhu L, Han J, Yuan R, Xue L, Pang W (2018a) Berberine ameliorates diabetic nephropathy by inhibiting TLR4\/NF-\u03baB pathway. Biol Res 51:1\u201312. https:\/\/doi.org\/10.1186\/s40659-018-0157-8","journal-title":"Biol Res"},{"key":"1555_CR234","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.biopha.2018.07.045","volume":"106","author":"X Zhu","year":"2018","unstructured":"Zhu X, Shi J, Li H (2018b) Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-\u03baB and NLRP3 inflammasome pathways. Biomed Pharmacother 106:976\u2013982. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.045","journal-title":"Biomed Pharmacother"},{"key":"1555_CR235","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110711","volume":"385","author":"W Zhu","year":"2023","unstructured":"Zhu W, Chen M, Wang Y, Chen Y, Zhang Y, Wang Y, Liu P, Li P (2023) Regulation of renal lipid deposition in diabetic nephropathy on morroniside via inhibition of NF-\u03baB\/TNF-a\/SREBP1c signaling pathway. Chem Biol Interact 385:110711. https:\/\/doi.org\/10.1016\/j.cbi.2023.110711","journal-title":"Chem Biol Interact"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-025-01555-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-025-01555-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-025-01555-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T22:27:13Z","timestamp":1757284033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-025-01555-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":237,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1555"],"URL":"https:\/\/doi.org\/10.1007\/s12272-025-01555-z","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that they have no known competing financial interest or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}